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Abstract 
 
 
Mucoadhesive dosage forms are delivery systems able to adhere to a particular region 
of the body for extended periods of time. This can lead to several advantages, such as 
a reduction of the administration frequency and an enhancement of drug 
bioavailability. For this reason, the phenomenon of mucoadhesion is widely studied, 
despite not fully understood. 
The mucoadhesive properties come from polymers, especially hydrophilic polymers 
becoming adhesive once activated by moistening. The mucoadhesive polymers play 
the key role in determining the mucoadhesive ability of a dosage form. Hence, it is 
necessary to deepen the study of the polymers properties. 
The present research mainly focuses on the screening of different mucoadhesive 
polymers for the development of mucoadhesive tablets with intestinal target. 
Particularly, this research aims to study different factors affecting mucoadhesion in 
order to identify the most important one that might predict the mucoadhesive ability 
of the final solid dosage form. 
Results of research activities are summarized in five chapters: 
- Chapter 1 gives an overview on the phenomenon of mucoadhesion, and the 
methods for the detection of the mucoadhesive properties; 
- in Chapter 2 the methods developed for the study of tablets mucoadhesive 
properties are presented; 
- the influence of the amount of polymer on the mucoadhesive properties and 
on the release rate of a model drug (sodium butyrate) is analyzed in Chapter 3; 
- in Chapter 4 the Design of Experiment (DoE) techniques are used to develop 
tablets with good mucoadhesive properties and an extended-release, 
containing sodium butyrate or mesalazine as active ingredients; 
- Conclusions and proposals for the future work can be found in Chapter 5. 
 
  
 
Riassunto 
 
 
Le formulazioni mucoadesive sono sistemi in grado di aderire ad una particolare 
regione del corpo per un tempo prolungato. Numerosi sono i vantaggi che ne 
derivano, tra cui la riduzione della frequenza di somministrazione del farmaco ed 
anche un possibile aumento della biodisponibilità. Per questo motivo, il fenomeno di 
mucoadesione è ampiamente studiato in campo scientifico. Nonostante ciò, a causa 
della sua complessità non è stato ancora compreso del tutto. 
Le proprietà mucoadesive di una formulazione derivano dalla presenza di polimeri, 
generalmente idrofilici, in grado di aderire alle mucose in seguito ad idratazione. I 
polimeri mucoadesivi, quindi, ricoprono un ruolo chiave nel determinare le capacità 
mucoadesive di una formulazione e risulta fondamentale studiare in maniera 
approfondita le proprietà del polimero. 
Il focus della presente ricerca è lo screening di diversi polimeri, al fine di sviluppare 
compresse mucoadesive che abbiano come target la mucosa intestinale. In 
particolare, sono stati studiati diversi fattori in grado di influenzare le proprietà 
mucoadesive di una formulazione allo scopo di individuare la proprietà più 
importante che potrebbe fornire un’informazione di tipo predittivo sulla capacità 
mucoadesiva del prodotto finito. 
I risultati di questo studio sono riassunti in cinque capitoli: 
- il Capitolo 1 fornisce una panoramica sul processo di mucoadesione e sui 
metodi per valutare le proprietà mucoadesive; 
- il Capitolo 2 presenta i metodi, che sono stati sviluppati in questo lavoro di 
ricerca, per lo studio delle proprietà mucoadesive delle compresse; 
- nel Capitolo 3 viene analizzata l'influenza della quantità di polimero sulle 
proprietà mucoadesive e sulla velocità di rilascio di un farmaco modello 
(sodio butirrato); 
  
 
 
- nel Capitolo 4 vengono impiegate tecniche di Disegno Sperimentale al fine di 
sviluppare compresse mucoadesive a rilascio prolungato contenenti sodio 
butirrato o mesalazina come principi attivi; 
- Conclusioni e prospettive future sono esposte nel Capitolo 5. 
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 Chapter 1 
Introduction 
 
 
1.1 Definition of adhesion, bioadhesion and mucoadhesion 
Adhesion, bioadhesion and mucoadhesion are three terms which refer to the same 
process taking place in different environments. 
Adhesion is defined as an interfacial phenomenon in which two materials are held 
together for extended periods of time by interfacial forces (Chowdary & Srinivasa 
Rao, 2004; Smart, 2005). When adhesion occurs in a biological setting, and at least 
one of the two materials is biological, it is termed “bioadhesion” (Andrews, et al., 
2009). The attachment could be between an artificial material such as a polymer and a 
biological substrate (Chowdary & Srinivasa Rao, 2004). When this substrate is 
represented by a mucous membrane the term “mucoadhesion” is used (Andrews, et 
al., 2009). In the pharmaceutical sciences this concept is referred to pharmaceutical 
dosage forms called “mucoadhesives” since they are able to adhere to the mucus layer 
of a mucosal tissue (figure 1.1). 
 
 
 
Figure 1.1. The mucoadhesive joint between a mucoadhesive dosage form and a mucosal 
tissue (Smart, 2005). 
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1.2 Mucoadhesive dosage forms 
Mucoadhesive dosage forms are delivery systems in which the bioadhesive properties 
of polymers allow to target a drug to a particular region of the body for extended 
periods of time (Chowdary & Srinivasa Rao, 2004).  
Mucoadhesive drug delivery systems may be formulated in different types of dosage 
form (e.g. tablets, films, gels, micro- and nano-particulate suspensions, in situ gelling 
systems and sprays) for various administration routes (e.g. ocular, nasal, buccal, 
gastrointestinal, vaginal and rectal) (Khutoryanskiy, 2011). As a consequence, they 
seem to be very smart and several studies reported in literature prove their great 
potential. 
 
1.2.1 Advantages of mucoadhesive dosage forms 
Compared to conventional dosage forms, the mucoadhesive drug delivery systems 
show various advantages:  
(i) they prolong residence time of the dosage form at the site of application 
and absorption, with a reduction of the administration frequency; 
(ii) a more intimate contact of the dosage form with the underlying absorption 
surface is facilitated; this may also allow a change of tissue permeability 
by modifying the tight junctions between the cells and hence the 
absorption of macromolecules, such as peptides and proteins; moreover, it 
may also lead to a possible improvement and enhancement of drugs 
bioavailability; 
(iii) possibility of site-specific drug delivery (Khutoryanskiy, 2011; Chowdary 
& Srinivasa Rao, 2004). 
 
1.3 Structure and function of mucus 
Mucus is a complex viscous adherent secretion synthesized by specialized goblet 
cells in the columnar epithelium that lines the walls of all the body cavities that are 
exposed to the external environment, such as the gastrointestinal, respiratory and 
reproductive tracts and also oculo-rhino-otolaryngeal tracts (Chowdary & Srinivasa 
Rao, 2004; Smart, 2005; Kharenko, et al., 2009; Bansil & Turner, 2006). 
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In those locations it serves many functions, such as the lubrication for the passage of 
substances, the maintenance of a hydrated layer over the epithelium, the action as a 
barrier to infectious agents and noxious substances and as a permeable gel layer for 
the exchange of gases and nutrients with the underlying epithelium (Bansil & Turner, 
2006). Specifically, in the gastro-intestinal tract the mucus facilitates the movement 
of food boluses along the digestive canal and helps shield the epithelium from 
proteolytic enzymes and shear forces induced by peristaltic waves (Kharenko, et al., 
2009; Peppas & Sahlin, 1996). Mucus lost due to degradation and turbulence is 
replaced by the constant secretion of mucus (Peppas & Sahlin, 1996). 
Mucus is composed mainly of water (95%), but also contains salts, lipids such as 
fatty acids, phospholipids and cholesterol, proteins with a defensive role such as 
lysozyme, immunoglobulins, defensins, growth factors and trefoil factors (Bansil & 
Turner, 2006). However, the main component responsible for its viscous and elastic 
gel-like properties is the glycoprotein mucin (Bansil & Turner, 2006). 
The mucous gel covering the epithelium varies in thickness. In the human stomach 
the mean thickness is 192 m, while in the duodenum the thickness ranges from 10 to 
400 m. Cohesion of the gel is dependent upon the glycoprotein concentration 
(Peppas & Sahlin, 1996). 
Mucus may be secreted either constantly or intermittently. The amount of mucus 
secreted changes under the influence of external and internal factors (Kharenko, et al., 
2009). 
 
1.3.1 Mucin 
The term “mucin” (MUC for human) refers to members of a glycoproteins family 
representing the major structural components of the mucus and responsible for mucus 
gelatinous structure, cohesion, and antiadhesive properties (Andrianifahanana, et al., 
2006; Kharenko, et al., 2009). 
Currently, at least 19 human mucins have been identified: MUC1, -2, -3A, -3B, -4, -
5AC, -5B, -6, -7, -8, -9, -11, -12, -13, -15, -16, -17, -19, and -20 (Andrianifahanana, 
et al., 2006; Bansil & Turner, 2006). These mucins may be classified in two main 
groups: the “secreted (gel-forming and non-gel-forming) mucins” and the 
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“membrane-bound mucins” which anchor to the plasmalemma by a transmembrane 
domain; they differ for structural characteristics and physiological fates (figure 1.2) 
(Andrianifahanana, et al., 2006). 
 
 
 
Figure 1.2. Typical expression of mucins at the epithelium–lumen interface: membrane-
bound mucins form the glycocalyx, whereas secreted mucins are the major components of the 
gel-like mucus layer. Examples shown include MUC1 (red) and MUC4 (green) for 
membrane-bound mucins, MUC2 (blue) and MUC5AC (pink) for secreted gel-forming 
mucins, and MUC7 (yellow) for secreted non-gel-forming mucins (Andrianifahanana, et al., 
2006). 
 
Mucin is produced by epithelial cells of various organs belonging to respiratory, 
digestive, reproductive, otologic, ocular, and urinary systems (Andrianifahanana, et 
al., 2006). 
Despite the type and the body site, glycoproteins usually have similar structure and 
are highly glycosylated protein molecules with molecular weights ranging from 0.5 to 
20 MDa. The sugar moieties consist of about 80% of mucin molecular mass, while 
the remaining 20% is represented by the protein core, termed “apomucin” (Bansil & 
Turner, 2006; Andrianifahanana, et al., 2006; Kharenko, et al., 2009). 
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Glycoproteins form a branched three-dimensional network with large numbers of 
loops (Kharenko, et al., 2009). The macromolecules associate with one another 
through non-covalent bonds forming a highly entangled network: this molecular 
association is central to the structure of mucus and is responsible for its rheological 
properties (Andrews, et al., 2009). 
Mucin glycoproteins may be described as consisting of a basic unit made from a 
single-chain polypeptide backbone (protein core) characterized by two types of area 
(figure 1.3): (1) heavily glycosylated regions where many large carbohydrate side 
chains are attached, predominantly via O-glycosidic linkages, and (2) terminal “naked 
proteins regions” where there is little glycosylation (Andrews, et al., 2009; Kharenko, 
et al., 2009). Glycosylation increases the resistance of the molecules to proteolytic 
hydrolysis (Kharenko, et al., 2009). 
 
 
Figure 1.3. Mucin structure (Andrews, et al., 2009). 
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The polypeptide chain consists of 800-4500 amino acid residues (Andrianifahanana, 
et al., 2006; Kharenko, et al., 2009). The glycoprotein C- and N-terminal domains 
contain more than 10% of cysteine which is responsible for the formation of large 
mucin oligomers via disulfide bonds (Kharenko, et al., 2009). The greater part of the 
protein backbone consists of a repeating sequence of serine, threonine, and proline 
residues (STP tandem repeats) (Kharenko, et al., 2009).  
Oligosaccharide branches are attached to 63% of the protein core, at about every 
three residues within the glycosylated regions, with the result that there are 
approximately 200 carbohydrate side chains per glycoprotein molecule; sugar side 
chains are linked to the hydroxyl side chains of serine and threonines by O-glycosidic 
bonds and arranged in a “bottle brush” configuration about the protein core. Each side 
chain contains between 2 and 20 sugar residues, primarily N-acetylgalactosamine, N-
acetylglucosamine, fucose, galactose, sialic acid and traces of mannose and sulfate 
(Peppas & Sahlin, 1996; Kharenko, et al., 2009; Bansil & Turner, 2006). As chains 
usually terminate with either fucose or sialic acid (N-acetylneuraminic acid, pKa = 
2.6), the glycoproteins are negatively charged at physiological pH values (Kharenko, 
et al., 2009). 
Mucin is stored in both submucosal and goblet cells, where calcium ions provide to 
shield the negative charges of the molecule, allowing the compact packing of such 
molecules. When mucin molecules are released into lumen, the outflux of calcium 
determines the exposition of negative charges which repulse each other leading to the 
expansion of the molecule. This is followed by the entanglement of mucin chains and 
the formation of non-covalent interactions such as hydrogen, electrostatic, and 
hydrophobic bonds, with the subsequent development of a viscoelastic gel. In the 
presence of water, these mucin chains overlap, interpenetrate and form a structured 
network that mechanically functions as mucus. The rheological behavior of mucus is 
a result of flow resistance of individual chains, entanglement and non-covalent 
intermolecular bonding (Andrews, et al., 2009). 
The main function of mucin consists in the protection, lubrication and hydration of 
the external surfaces of epithelial tissue layers lining human body ducts and lumen. 
Moreover, certain types of mucin are involved also in more sophisticated biological 
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processes such as epithelial cell renewal and differentiation, cell signaling, and cell 
adhesion. Since mucin serves several functions, an alteration of its production and/or 
a change of its biochemical characteristics may have a negative effect on cell 
behavior. The deregulated expression and/or aberrant glycosylation of mucins have 
indeed been associated with various pathological conditions, including malignant and 
inflammatory disorders (Andrianifahanana, et al., 2006). 
 
1.4 The mucoadhesive/mucosa interaction  
In order to develop a mucoadhesive dosage form it is necessary to understand the 
mucoadhesion phenomenon, the forces and mechanisms that lead to an effective bond 
between the polymer and the mucus layer (Serra, et al., 2009). 
 
1.4.1 Bio/mucoadhesive forces 
For mucoadhesion to occur, different kinds of interfacial phenomena and forces arise 
at the interface mucoadhesive/mucosa, including: 
(i) mechanical and physical interactions such as tangling of polymer and 
mucin chains; 
(ii) hydrogen bonds formed by hydroxyls, carboxyls, sulfate and amino 
groups and generally weaker than ionic or covalent bonds; 
(iii) van der Waals bonds which are probably the weakest form of interaction; 
(iv) hydrophobic bonds which are indirect bonds occurring when non polar-
groups are present in aqueous solutions; these groups associate with each 
other to minimize the effect produced by water molecules; 
(v) ionic bonds formed by electrostatic interaction of two oppositely charged 
ions (Smart, 2005); 
(vi) covalent bonds which are strong bonds like the previous (v) and are 
attained by the chemical reaction of the polymer and the substrate (Serra, 
et al., 2009); an example of covalent bond is represented by the disulfide 
bridge S-S arising from the oxidation of two sulfhydryl (-SH) groups 
(Sudhakar, et al., 2006); 
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(vii) recognition of specific ligands (lectins-sugars, etc.) (Kharenko, et al., 
2009). 
 
Hence, three main types of interaction between a polymer and the mucus layer exist: 
mechanical or physical bonds (i), secondary chemical bonds (ii, iii, iv) and primary 
chemical bonds (v,vi) (Serra, et al., 2009). 
Although van der Waals interactions and hydrogen bonds are weaker than covalent or 
ionic bonds, quite strong adhesion can also be achieved with this kind of forces by the 
formation of large numbers of interaction sites (Kharenko, et al., 2009). For example, 
anionic polyelectrolytes, characterized by high molecular weight and high polar 
group contents (such as carboxyl and hydroxyl groups), may exhibit great 
mucoadhesive properties with a minimum of toxic effects (Kharenko, et al., 2009).  
Nevertheless, even with covalent bonds which are permanent, the effectiveness of the 
mucoadhesive dosage form should be evaluated in light of mucus turnover and 
epithelial desquamation (Serra, et al., 2009). 
Moreover, it must be considered that the interaction between two molecules is 
composed not only of attraction but also of repulsion. Indeed, besides the attractive 
forces previously listed, also repulsive interactions, such as electrostatic and steric 
repulsion, exist. While attractive forces favor adhesion, repulsive ones oppose it. 
Hence both forces must be considered in the development of a mucoadhesive dosage 
form (Sudhakar, et al., 2006). 
 
1.4.2 Types of mucoadhesive/mucosa interactions 
Considering the mechanism of mucoadhesion, different kinds of interaction can arise, 
depending on the type of the mucoadhesive dosage form and the type of mucosal 
surface: 
(i) dry or partially hydrated mucoadhesive dosage forms coming in contact 
with considerable and continuous mucus layers, as shown in section a) 
figure 1.4; 
(ii) fully hydrated mucoadhesive dosage forms coming in contact with 
considerable and continuous mucus layers (section b) figure 1.4); 
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(iii) dry or partially hydrated mucoadhesive dosage forms coming in contact 
with thin and discontinuous mucus layers (section c) figure 1.4); 
(iv) fully hydrated mucoadhesive dosage forms coming in contact with thin 
and discontinuous mucus layers (section d) figure 1.4) (Kharenko, et al., 
2009; Smart, 2005). 
 
 
Figure 1.4. Examples of different kinds of mucoadhesive/mucosa interaction: a) aerosolized 
particles on the nasal mucus layer; b) particle suspensions on the gastrointestinal mucus 
layer; c) tablets or patches on the buccal or vaginal mucus layers; d) liquids or aqueous 
semisolids as gels administered into esophagus, eye or for vaginal delivery (modified from 
Smart, 2005). 
 
1.4.3 Theories of Mucoadhesion 
Mucoadhesion is a complex phenomenon that has not been fully understood. So far, 
several general theories of adhesion based on different kind of physical or chemical 
interactions have been used to explain the process (Khutoryanskiy, 2011). Indeed, as 
a) b) 
c) d) 
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seen previously, mucoadhesion can occur between different types of mucous 
membranes and drug delivery systems, which may be solid, viscous, or liquid. As a 
consequence, there is not a single universal theory able to explain all of these 
different situations but mucoadhesion probably results from a combination of the 
following theories (Khutoryanskiy, 2011; Kharenko, et al., 2009): 
(i) the electronic theory suggests that an electronic transfer occurs between 
mucoadhesive polymer and mucus when these two surfaces exhibit 
different electronic characteristics. This results in the formation of a 
double layer of electrical charges at the mucus and mucoadhesive 
interface with subsequent adhesion due to electrostatic attraction between 
oppositely charged surfaces (Smart, 2005; Andrews, et al., 2009; 
Khutoryanskiy, 2011).  
(ii) The adsorption theory considers adhesion as the result of various chemical 
interactions (primary and secondary bonding) between the adhesive 
polymer and the mucous substrate. As seen previously, primary bonds 
consist in ionic, covalent and metallic bonding, while secondary bonds 
consist in hydrogen bonds, van der Waals forces and hydrophobic 
interactions. The last one may also play an important role, especially when 
the mucoadhesive polymers have an amphiphilic nature; hydrophobic 
interactions can also explain the bioadhesivity of hydrophobic substrates 
(Andrews, et al., 2009; Khutoryanskiy, 2011; Lee, et al., 2000). On the 
other hand, for a bioadhesive polymer with a carboxyl group, hydrogen 
bonding is considered to be the dominant force at the interface (Lee, et al., 
2000).  
(iii) The wetting theory correlates the surface tension of mucus/mucoadhesive 
polymer and their interfacial energy with the polymer ability to spread on 
the mucus layer, considering such ability as a prerequisite for the 
development of adhesion. Therefore, polymers able to spread 
spontaneously onto the mucus surface, show greater mucoadhesive 
performances (Khutoryanskiy, 2011; Smart, 2005). This theory is mainly 
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applicable to liquid or low viscosity mucoadhesive dosage forms 
(Andrews, et al., 2009).  
(iv) The diffusion-interlocking theory proposes the time-dependent diffusion 
of mucoadhesive polymer chains into gaps, loops and pores of the 
glycoprotein chain network (of the mucus layer) and the diffusion of 
glycoprotein mucin chains into the polymer matrix until an equilibrium 
penetration depth is achieved (figure 1.5). Hence, it consists of a two-way 
diffusion process driven by the concentration gradients of the two 
materials. The penetration rate and the depth of interpenetration depend 
upon the diffusion coefficients of both interacting layers and the contact 
time (Andrews, et al., 2009; Khutoryanskiy, 2011; Shaikh, et al., 2011; 
Jiménez-Castellanos, et al., 1993; Kharenko, et al., 2009).  
 
 
Figure 1.5. The diffusion-interlocking theory of adhesion. a) Yellow (polymer) 
layer and blue (mucus) layer before contact; b) upon contact; c) diffusion after 
contact for a period of time and creation of a semipermanent adhesive bond 
(Andrews, et al., 2009). 
 
The mean diffusional depth of the bioadhesive polymer segments, s, may 
be represented by the following equation: 
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  √        (1.1) 
 
where D is the diffusion coefficient and t is the contact time (Shaikh, et al., 
2011). 
Efficient adhesion is normally achieved when the thickness of 
interpenetration layer reaches 0.2–0.5 m (Khutoryanskiy, 2011). 
This process is also influenced by the molecular weight of mucoadhesive 
macromolecules, their hydrodynamic size and cross-linking density, chain 
mobility/flexibility and expansion capacity of both networks (Andrews, et 
al., 2009; Khutoryanskiy, 2011).  
(v) The fracture theory relates the force required for polymer detachment 
from the mucus to the strength of their adhesive bond (Andrews, et al., 
2009). This force is related to the mucoadhesive capabilities of the 
polymer (Serra, et al., 2009). The fracture theory is considered to be 
appropriate to describe the adhesion process involving rigid mucoadhesive 
materials (Khutoryanskiy, 2011; Shaikh, et al., 2011). 
(vi) The mechanical theory involves rough and porous materials and suggests 
that surface roughness favors adhesion due to an increase in contact area 
(Khutoryanskiy, 2011).  
 
1.4.4 The mucoadhesion process 
Considering the different types of interaction that can occur between the dosage form 
and the mucus layer, the mucoadhesion phenomenon could be seen as a process 
composed of sequential phases, associated with different theories and mechanisms. 
The model considers two steps, illustrated in figure 1.6:  
(i) the contact stage (step 1), when an intimate contact occurs between the 
mucous membrane and the mucoadhesive dosage form, which spreads 
over the substrate, wets and swells (wetting theory); 
(ii) the consolidation stage (step 2), when various physicochemical 
interactions occur to consolidate and strengthen the mucoadhesive joint 
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(electronic, adsorption and diffusion-interlocking theories); the first bonds 
to be created are non-covalent, then further non-covalent and covalent 
bonds are formed, due to the interpenetration of the polymer and mucin 
chains (Smart, 2005; Khutoryanskiy, 2011).  
 
 
Figure 1.6. The two steps of the mucoadhesion process (modified from Smart, 2005). 
 
The initial contact could be induced mechanically, e.g. placing the dosage form in the 
buccal cavity, eye or vagina. Alternatively, the deposition of the dosage form could 
happen exploiting the aerodynamics of the organ such as in the respiratory tract or 
peristalsis and other movements of the gastrointestinal tract (Smart, 2005). 
Obviously, an increase in the applied pressure favors the intimate contact because it 
causes a viscoelastic deformation at the interface (Lee, et al., 2000).  
Smart (Smart, 2005) applied the DLVO theory, developed in the 1940s by Derjaguin 
and Landau (Derjaguin & Landau, 1941) and by Verwey and Overbeek (Vervey & 
Overbeek, 1948), in order to describe the adsorption process of the dosage form. In 
case of small particles their movement within the body depends on Brownian motion, 
the flow of liquids within body cavities and body movements like peristalsis. As 
mentioned in Section 1.4.1, when a particle comes in close contact with a surface 
both repulsive and attractive forces arise (Smart, 2005). The relative strength of these 
opposing forces depends on the nature of the particle, the aqueous environment and 
Interaction 
area 
Mucoadhesive 
dosage form 
Mucus layer 
Epithelial 
cells 
1. Contact stage 2. Consolidation stage 
Contact 
Wetting & Swelling 
Physicochemical 
interactions 
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the distance between the particle and the surface. In particular, smaller particles have 
a greater surface area-volume ratio, and as a result, the attractive forces may be 
greater too (Smart, 2005). Regarding the distance, as shown in figure 1.7, at a certain 
distance of about 10 nm (secondary minimum) particles can be weakly held because 
the attractive forces are balanced by the repulsive ones. In order to obtain a stronger 
adsorption, particles must overcome a repulsive barrier (energy barrier in the graph) 
and after that the primary minimum (around 1 nm) can be achieved (Smart, 2005). 
 
 
Figure 1.7. Repulsive and attractive forces as a function of distance of separation on the 
bases of DLVO theory, where Vi are the potential energies (modified from Florence & 
Attwood, 1998). 
 
However, it must be considered that in-vivo the surface with which the particles come 
in contact is not a solid but a mucus gel. Moreover, the particles may be subjected to 
processes of hydration or coating with biomolecules, with, as a result, a possible 
change of their physicochemical properties (Smart, 2005).  
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The presence of folds and crevasses on the mucous membranes of the gastrointestinal 
tract and of an unstirred water layer at the surface permits the retention of the dosage 
form at that level with only weak adhesive forces (Smart, 2005). 
On the other hand, if strong or prolonged adhesion is required, for example in case of 
larger formulations exposed to stresses such as blinking or mouth movements, then a 
second consolidation stage is necessary (Smart, 2005). In order to adhere to the 
surface, mucoadhesive materials must be activated by the presence of moisture, 
which acts as a plasticizer. In these conditions the mucoadhesive molecules become 
free, conform to the shape of the surface, and bond predominantly by weaker van der 
Waals and hydrogen bonding but also, in the case of cationic materials, by 
electrostatic interactions with the mucin negatively charged groups (such as carboxyl 
or sulphate) (Smart, 2005).  
In relation to the mucus characteristics a dosage form can establish the adhesive joint 
more or less easily. Indeed, in case of surfaces with only limited amounts of mucus, a 
dry mucoadhesive polymer dehydrate without difficulty the mucus gel by extracting 
its water component, allowing the polymer molecules the freedom to form hydrogen 
bonds with the epithelial surface (Smart, 2005). 
On the other hand, in presence of a substantial mucus layer, the formation of the 
adhesive joint may be reached less easily because there is the need to overcome the 
anti-adherent properties of mucus and hence a change in the physical properties of the 
mucus layer is necessary (Smart, 2005).  
Considering the adhesive joint as composed of three regions, the mucoadhesive 
material, the mucosa and an interfacial region, two theories for the consolidation 
process may be developed (Smart, 2005).  
The first theory is based largely on the diffusion-interlocking theory and considers the 
interpenetration of the mucoadhesive and mucin macromolecules and, subsequently, 
the formation of secondary interactions (Smart, 2005).  
In the case of dry or partially hydrated formulations come into contact with a 
substantial mucus gel, a second theory could be used to explain the adhesion 
mechanism. In this case a water movement occurs until the equilibrium is reached 
(dehydration process) (figure 1.8) (Smart, 2005). In particular, in the case of 
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polyelectrolyte gels, characterized by a marked affinity for water, a high osmotic 
pressure is established with a significant swelling of the dosage form. When the 
swollen dosage form comes into contact with the mucus gel, the process of 
dehydration will occur rapidly and a consolidation of the mucus joint will be 
achieved (Smart, 2005).  
 
 
Figure 1.8. The dehydration theory of mucoadhesion (Smart, 2005). 
 
Due to dehydration, the mucus gel becomes adhesive (Mortazavi & Smart, 1993). 
 
1.5 Factors affecting mucoadhesion 
Since mucoadhesion is a very complex phenomenon, the strength of the adhesive 
joint may be influenced by different factors related to the characteristics of the 
mucoadhesive material and the mucosa but also the environment. 
 
1.5.1 Properties of the mucoadhesive polymer 
Numerous are the properties of the polymer involve in its ability to adhere to a 
mucosal tissue. Among these are included the following: 
(i) hydrophilicity or the presence of hydrophilic functional groups (such as 
hydroxyl, carboxyl, amide, sulphate), which are able to form hydrogen 
bonds with the substrate and lead to the swelling of the polymer in 
aqueous medium. In the swollen polymer the chains are at the maximum 
distance; this leads to an increase of their flexibility and a more efficient 
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interpenetration with the mucin glycoproteins and thus the maximum 
exposure of potential docking sites is achieved. However, when hydration 
and swelling are too high a slimy mucilage, which can be easily removed 
from the substrate, is obtained. Depending on the type of polymer, the 
degree of hydration which corresponds to the maximum adhesion varies. 
(ii) Molecular weight (Mw) and spatial conformation. Low-molecular-weight 
polymers penetrate the mucus layer better than high-molecular-weight 
polymers which, on the contrary, promote physical entanglement. The 
optimum molecular weight for the maximum mucoadhesion depends on 
the type of polymer used, but generally it ranges between 10 kDa and 
4000 kDa. Polymers with a Mw higher than 4000 kDa will not moisten 
easily and thus the exposure of the free group is limited, while polymers 
with a Mw lower than 10 kDa form weak gels or dissolve quickly. In 
general it is observed that for linear polymers, the bioadhesive forces 
increase with increasing molecular weight up to 100 kDa and beyond this 
level there is not much effect. But it must be considered that, although a 
critical length of the molecules is necessary for interpenetration and 
molecular entanglement, also size and spatial conformation of the 
adhesive macromolecules could affect the mucoadhesive capability. For 
example, dextran with very high molecular weight (about 20000 kDa) 
shows adhesive strength similar to that of polyethylene glycol (PEG) with 
a molecular weight of 200 kDa; this is due to the fact that the helical 
conformation of dextran may shield many adhesively active groups while 
PEG is linear. 
(iii) Cross-linking and swelling which are inversely proportional. The lower 
the cross-linking density, the higher the polymer chain flexibility, the 
hydration rate and, hence, the degree of swelling. Indeed, polymer chain 
flexibility and swelling are required for the diffusion of polymer chains 
and the exposure of sites for the formation of bonds and the mechanical 
entangling with mucin. Therefore the exposure of a larger surface area 
determines better mucoadhesive properties. On the other hand, for 
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polymers with the tendency to overhydrate, cross-linking could have a 
positive effect. 
(iv) Concentration. The optimum concentration for the maximum 
mucoadhesion depends on the type of polymer. Considering liquid 
formulations or similar, when the polymer concentration is too high the 
solution becomes solvent-poor and the chains available for 
interpenetration are not numerous so the mucoadhesive properties 
decrease. In the case of solid dosage forms, such as tablets, the strength of 
the adhesive joint increases with increasing of the polymer concentration. 
(v) Charge density of macromolecules. The presence of surface charges 
permits the formation of electrostatic interactions between polymer and 
the negative charges of mucin glycoproteins (Shaikh, et al., 2011; Smart, 
2005; Jiménez-Castellanos, et al., 1993). 
 
1.5.2 Environmental factors 
Besides polymer properties, the environment can also influence the mucoadhesive 
ability of the dosage form in different ways: 
(i) pH changes which can lead to differences in the dissociation degree of 
ionizable functional groups of both glycoprotein and polymer chains and, 
hence, can modify the charge density of the macromolecules. As a 
consequence, for example, at high pH values the carboxyl functional 
groups are in the dissociated form and thus a change in the spatial 
conformation of the macromolecule from a coiled state to a rod-like 
structure more suitable for chain interpenetration could be achieved 
(Andrews, et al., 2009; Jiménez-Castellanos, et al., 1993). However, the 
negative charges due to the dissociated functional groups could produce 
also repulsion forces.  
(ii) Initial contact time between the mucus layer and the dosage form, which 
is directly proportional with the mucoadhesive strength of the dosage form 
because the initial contact time influences the swelling degree of the 
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dosage form and the extent of interpenetration of polymer and mucin 
chains (Lee, et al., 2000; Kharenko, et al., 2009).  
(iii) Contact force which is directly proportional with the depth of diffusion of 
the chains (Kharenko, et al., 2009).  
(iv) Ionic strength of the surrounding medium which influence the 
mucoadhesion strength because metal ions may shield chains functional 
sites reducing swelling and mucoadhesive force (Andrews, et al., 2009); 
on the other hand the presence of divalent cations may induce gel 
formation, as in the case of sodium alginate and calcium salt.  
(v) Moistening which is required to allow the expansion and mobility of 
polymer chains and, hence, create a “macromolecular network” of 
sufficient size for the interpenetration of polymer and mucin molecules 
(Kharenko, et al., 2009).  
 
1.5.3 Physiological factors 
Physiological variables can also affect mucoadhesion: 
(i) mucus turnover, i.e. the time required to replenish the mucus layer, which 
varies from a few hours to a day depending on the body sites. It increases 
in presence of pathogens and may limit the retention of the dosage form at 
the site of action and hence its effectiveness. This is less important in the 
case of mucosal tissue with a relatively low mucus turnover (e.g. mouth or 
vagina) while in areas of markedly high mucus turnover (e.g. intestines), 
adherence time probably don’t overcome 2 hours.  
(ii) Mucus viscosity which varies depending on the body sites. The viscosity 
should be not too low but also not too high, because in the first case the 
polymer/mucus bond would be weak and easily detachable, in the other 
case the thick mucus layer would function as a barrier and the 
interpenetration and diffusion processes are limited.  
(iii) Concomitant diseases (e.g. ulcer disease, colitis, allergic rhinitis, bacterial 
or fungal infection) which can modify the amount of secreted mucus and 
its physicochemical properties.  
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(iv) Tissue movement which can affect the mucoadhesive/mucosa contact and 
the retention time of the dosage form at the target site (e.g. peristalsis, 
blinking). 
 
1.6 Mucoadhesive polymers 
1.6.1 Polymer ideal characteristics 
An ideal mucoadhesive polymer should have the following characteristics: 
 hydrophilicity;  
 presence of strong anionic or cationic charges; 
 sufficient chain mobility to allow diffusion and interpenetration; 
 surface energy properties favoring the spreading onto mucus; 
 good swelling; 
 optimum molecular weight, spatial conformation and concentration for 
mucoadhesion; 
 an appropriate cross-linking degree in order to prevent overhydration unless 
suppression of bond forming groups; 
 fast adhesion to mucosa, ability to form a strong bond and possession of some 
site specificity; 
 presence of adhesively active groups;  
 sufficient mechanical strength; 
 biocompatibility and biodegradability; 
 polymer and its degradation products should be non-toxic, non-irritant; 
 easily available at low cost; 
 polymer must not decompose on storage or during the shelf life of the dosage 
form; 
 polymer should allow easy incorporation of the drug and offer no hindrance to 
its release (Kharenko, et al., 2009; Shaikh, et al., 2011; Sudhakar, et al., 2006; 
Lee, et al., 2000; Khutoryanskiy, 2011). 
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1.6.2 Classification of mucoadhesive polymers 
Mucoadhesive polymers are generally hydrophilic macromolecules, also called “wet 
adhesives” since they are activated by moistening. They can be divided into three 
main subsets, namely anionic, cationic and non-ionic polymers. Of these, anionic and 
cationic polymers have been shown to exhibit the greatest mucoadhesive strength 
(Smart, 2005). 
The mucoadhesiveness of anionic polymers, such as poly(acrylic acid), 
carboxymethylcellulose and sodium alginate, is related to the ability of the carboxylic 
groups to form hydrogen bonds with oligosaccharide chains of mucin while 
mucoadhesive properties of cationic polymers, e.g. chitosan, are mainly based on the 
electrostatic interaction occurring between their positive charges and the mucin 
negative charges (Khutoryanskiy, 2011). 
Beside wet adhesives, which represent traditional non-specific first-generation 
mucoadhesive polymers, in recent years a novel second-generation of mucoadhesive 
polymers has also been developed, including, lectins and thiolated polymers. Lectins 
are generally defined as proteins or glycoprotein complexes able to bind sugars 
selectively in a noncovalent manner. The thiolated polymers, also named thiomers, 
are hydrophilic macromolecules exhibiting free thiol groups on the polymeric 
backbone (Shaikh, et al., 2011). The presence of thiol groups in the polymer allows 
the formation of stable covalent bonds (disulfide bridges) with cysteine-rich 
subdomains of mucus glycoproteins. This can lead to an increase in the residence 
time and bioavailability (Khutoryanskiy, 2011; Shaikh, et al., 2011).  
 
1.7 Methods to study mucoadhesion 
In order to design and develop a mucoadhesive delivery system, it is fundamental the 
assessment of the mucoadhesive properties of materials and dosage forms. The 
methods developed to assess mucoadhesion include in vitro and in vivo techniques. 
The last ones always follow a screening, realized using in vitro techniques and aims 
to highlight the most promising mucoadhesive materials (Lee, et al., 2000). 
Nevertheless, there is only a limited number of in vivo studies in literature because of 
time, cost and ethical constrains (Shaikh, et al., 2011).  
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Several in vitro methods for the evaluation of mucoadhesive properties of different 
dosage forms, are reported in literature. The most common methods are those based 
on the measure of the force needed to break the adhesive joint, i.e. Atomic Force 
Microscopy and tensile methods using modified balances or tensile testers as Texture 
Analyser. Beside these methods, there are others based on particle interactions 
measurements which include mucin particle method and BIACORE, proposed by 
Takeuchi et al. (Takeuchi, et al., 2005), rheology. ellipsometry, and flow channel 
method (Woertz, et al., 2013; Khutoryanskiy, 2011).  
The main in vivo techniques for the evaluation of the mucoadhesive properties 
include gamma scintigraphy and magnetic resonance imaging (MRI), two non-
invasive techniques able to perform gastrointestinal transit studies (Lee, et al., 2000; 
Shaikh, et al., 2011). 
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2.1 Introduction 
Over the last three decades mucoadhesion has become of interest for its potentiality to 
increase the residence time of the dosage form at the site of action (local action, e.g. 
within the gastrointestinal tract) or absorption (systemic delivery, e.g. via the nasal 
cavity), improving drug bioavailability and reducing administration frequency 
(Khutoryanskiy, 2011; Smart, 2005). Furthermore the development of these systems 
is very flexible since mucoadhesive drug delivery systems may be formulated in 
different dosage forms (e.g. tablets, films, gels) and administered by various routes, 
such as ocular, nasal, buccal and gingival, gastrointestinal (oral), vaginal and rectal 
(Khutoryanskiy, 2011). All of these advantages have contributed to the expansion of 
the research and the market for this kind of products. 
These systems owed their mucoadhesive properties to materials, especially polymers, 
capable of adhere to a mucosal tissue. The main group of mucoadhesives is 
represented by hydrophilic macromolecules, containing groups (e.g. hydroxyl, 
carboxyl or amine groups) able to form numerous hydrogen bonds with the mucus 
layer. They are called “wet” adhesives because they are activated by moisture, which 
plasticizes the system allowing mucoadhesive molecules to become free, conform to 
the shape of the surface, and able to form van der Waals and hydrogen bonds with the 
mucus layer (Smart, 2005). This is a simplification since mucoadhesion is a complex 
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phenomenon, not yet fully understood, but certainly consisting of a combination of 
different interaction mechanisms (Khutoryanskiy, 2011).  
The degree of mucoadhesion is influenced by various polymer-based 
physicochemical properties, including molecular weight, chain flexibility, 
hydrophilicity, ability to form hydrogen bonds, concentration and swelling extent 
(Andrews, et al., 2009; Kharenko, et al., 2009). Moreover, there are also 
environmental and physiological factors, such as changing in pH or presence of 
concomitant diseases, which can influence the strength and duration of the 
mucoadhesive interaction (Kharenko, et al., 2009). 
In the design of a mucoadhesive drug delivery system all of these factors should be 
considered, first of all polymer properties. Therefore, in the development of these 
systems the choice of the polymer plays a key role in determining the success and the 
effective mucoadhesiveness of the final product. Hence, the importance of making a 
screening of different materials throughout the development of techniques for the 
detection of polymer properties related to its mucoadhesion capacity.  
 
2.1.1 Aim 
The research started with the screening of four anionic and natural polymers: sodium 
alginate (SA), tragacanth gum (TG), xanthan gum (XG) and k-carrageenan (KC).  
These polymers were used to realize tablets whose mucoadhesive properties were 
studied directly by means of a tensile test using a Texture Analyser and indirectly 
throughout the comparison of the results obtained from the tensile test and the ones 
derived from the evaluation of certain properties influencing mucoadhesion: water 
uptake and swelling of the dosage form and polymer molecular weight. This kind of 
“two-way approach” has been chosen to point out which is the best mucoadhesive 
polymer and how the mucoadhesive capacity is affected by polymer properties.  
 
2.2 Materials  
The following were used: sodium alginate E401 (Satialgine S1100), xanthan gum Ph. 
Eur.-USP, tragacanth gum powder NF18, talc PHARMA USP Ph.Eur., magnesium 
stearate FU-Ph.Eur., microcrystalline cellulose T1 Ph.Eur., sodium chloride, all seven 
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supplied by A.C.E.F. S.p.A. (Italy); Ludipress
®
 and mucin (from porcine stomach, 
type II) purchased from BASF The Chemical Company (Germany) and Sigma-
Aldrich (USA), respectively; Gelcarin GP 911NF K-Carrageenan supplied by IMCD 
UK LTD (United Kingdom). 
In all solutions, deionized water was used. 
Characteristics, properties and applications of the mucoadhesive polymers are 
described in detail in table 2.1. 
 
Table 2.1. Properties and application of the polymers used in the study. 
Polymers Properties Applications 
Gelcarin GP 911NF (K-Carrageenan) 
High molecular weight 
polysaccharide extracted from red 
seaweed of the class Rhodophyceae 
(especially from Eucheuma, 
Chondrus e Gigartina species). It 
consists chiefly of potassium, 
sodium, calcium, magnesium, and 
ammonium sulfate esters of 
galactose and 3,6-anhydrogalactose 
copolymers. These hexoses are 
alternately linked at the α-1,3 and β-
1,4 sites in the polymer. 
 
 
R=H 
 
(Rowe, et al., 2006; FMC Corporation, 
1993) 
 
 
Xanthan gum (Ph. Eur.-USP) 
High molecular weight extracellular 
heteropolysaccharide, produced by 
fermentation with the gram-negative 
bacterium, Xanthamonas campestris.  
 
 K-Carrageenan is a strongly 
gelling polymer which has a 
helical tertiary structure (formed 
with potassium ions) that allows 
gelling. It contains 25% ester 
sulfate by weight and 
approximately 34% 3,6- 
anhydrogalactose. 
 Hygroscopic polymer, soluble in 
water at 80°C and partially 
soluble in cold water. 
 Potassium salts form in water a 
firm gel structure which becomes 
tightly aggregated as the level of 
potassium is increased. Moreover 
the presence of divalent cations 
may cause helices to aggregate 
and the gel to contract. 
 Carrageenan is thermally 
reversible, so at high 
temperatures it will impart 
minimal viscosity to the system, 
while upon cooling it will 
thicken. 
 
 
 It contains a cellulosic backbone 
(β-D-glucose residues) and a 
trisaccharide side chain of β-D-
mannose-β-D-glucuronic acid-α- 
D-mannose attached with 
alternate glucose residues of the 
main chain. The terminal D-
mannose residue may carry a 
 It is used in the manufacture of 
stable gels, creams, lotions, eye 
drops, suppositories, tablets, 
and capsules. 
 It stabilizes existing emulsions 
and suspensions thanks to its 
thickening and thixotropic 
properties. 
 Incorporation of carrageenan 
into tablet matrices together 
with calcium or potassium salts 
leads to the formation of a gel 
which fosters drug sustained-
release.  
 Carrageenan has mucoadhesive 
properties and it can be used to 
produce mucoadhesive 
formulations for oral and 
buccal drug delivery. 
 
 
 
 
 
 
 
 It is used as a suspending, 
gelling, stabilizing, thickening, 
emulsifying, viscosity-
increasing agent and a binder 
in oral and topical 
pharmaceutical formulations, 
cosmetics, and foods.  
 It is also used to prepare 
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(Rowe, et al., 2006; Talukdar & 
Kinget, 1995) 
 
 
 
 
 
 
 
Sodium alginate (E401) 
Sodium salt of alginic acid, extracted 
from brown seaweed. 
 
 
 
(Rowe, et al., 2006) 
 
 
 
 
 
 
 
 
 
 
Tragacanth gum (powder NF18) 
Anionic polysaccharide of high 
pyruvate function, while the non-
terminal D-mannose unit in the 
side chain contains an acetyl 
function. 
 The rigid polymer chain may 
exist in solution as a single, 
double, or triple helix that 
interacts with other xanthan gum 
molecules to form complex, 
loosely bound networks. 
 It is prepared as the sodium, 
potassium, or calcium salt. 
 It is soluble in water while 
practically insoluble in ethanol 
and ether. 
 It is nontoxic, and it has good 
stability and viscosity properties 
over a wide pH and temperature 
ranges. 
 Xanthan gum gels show a 
pseudoplastic behavior. 
 
 
 Alginic acid is a linear 
copolymer composed of two 
monomeric units, D-mannuronic 
acid and L-guluronic acid. 
 A 1% [w/v] aqueous solution 
exhibits a pH of about 7.2. 
 It is a hygroscopic polymer, 
slowly soluble in water, where it 
forms a viscous colloidal 
solution. 
 Practically insoluble in most 
organic solvents and in aqueous 
acidic solutions in which the pH 
is less than 3. 
 Various grades of sodium 
alginate are commercially 
available that yield aqueous 
solutions of varying viscosity. 
Typically a 1% [w/v] aqueous 
solution, at 20°C, will have a 
viscosity of 20-400 mPa*s. 
Viscosity may vary depending 
upon concentration, pH, 
temperature, or the presence of 
metal ions. Above pH 10, 
viscosity decreases. 
 
 
 Sugar composition: galacturonic 
acid, xylose, fucose, arabinose, 
sustained-release formulations, 
such as matrix tablets.  
 It has been incorporated in an 
ophthalmic liquid dosage form, 
which interacts with mucin, 
thereby helping in the 
prolonged retention of the 
dosage form in the precorneal 
area. 
 It may be used to increase the 
bioadhesive strength in vaginal 
formulations and as a 
mucoadhesive controlled-
release excipient for buccal 
drug delivery. 
 Moreover it can be used as an 
excipient for controlled colonic 
drug delivery. 
 
 
 
 
 
 It is used in oral and topical 
pharmaceutical formulations as 
suspending agent, stabilizing 
agent, tablet and capsule 
disintegrant, tablet binder, 
diluent for capsules and 
viscosity increasing agent. 
 It is also used in the 
preparation of sustained-release 
oral formulations since it can 
delay the dissolution of a drug 
from tablets, capsules, and 
aqueous suspensions 
 Finally, it is used in the 
preparation of mucoadhesive 
dosage forms or ophthalmic 
solutions that form a gel in situ 
after administration. 
 
 
 
 
 
 
 
 
 
 
 Emulsifying, stabilizing, 
suspending and viscosity-
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molecular weight, obtained as a 
dried exudate from the stems and 
branches of Astragalus gummifer 
Labillardière and other species of 
Astragalus grown in Western Asia. 
It consists of two main fractions: a 
water-insoluble component 
(bassorin), which has the capacity to 
swell and form a gel, and a water-
soluble component (tragacanthin). 
 
 
 
(Rowe, et al., 2006; Balaghi, et al., 
2011) 
 
galactose, glucose, and traces of 
rhamnose. The proportions of 
each sugar vary among the gums 
from various species of 
Astragalus. 
 Molecular weight of about 
840kDa. 
 The viscosity of tragacanth 
dispersions varies according to 
the grade and source of the 
material. Typically, 1% [w/v] 
dispersions may range in 
viscosity from 100-4000 mPa*s 
at 20°C. Viscosity increases with 
increasing temperature and 
concentration, and decreases 
with increasing pH. Maximum 
initial viscosity occurs at pH 8, 
although the greatest stability of 
tragacanth dispersions occurs at 
about pH 5. 
 Practically insoluble in water, 
ethanol (95%) and other organic 
solvents. In water it swells 
rapidly forming viscous colloidal 
solutions or gels. 
 A 1% [w/v] aqueous dispersion 
has a pH of 5-6. 
 Highly acid-resistant 
hydrocolloid. 
 
increasing agent. 
 Diluent in tablet formulations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3 Methods 
2.3.1 Determination of intrinsic viscosity and Viscosity Average Molecular 
Weight of polymers 
Intrinsic viscosity determination was carried out with a 0.46 mm diameter Ubbelohde 
capillary viscosimeter (Schott-Geräte GmbH, Germany) immersed in a heated 
circulating water bath to maintain a constant temperature of 25°C for all polymers.  
For each polymer, solutions with decreasing concentration in the range of 0.25-
0.03g*dL
-1
 were prepared. Elution time of each sample was measured five times and 
the average elution time was then calculated. The corresponding reduced viscosities 
were obtained by the following equation: 
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     (2.1) 
 
where      is the reduced viscosity,   is the average elution time,    is the average 
elution time of the solvent and   is the solution concentration.  
Reduced viscosity versus concentration curves were then constructed and intrinsic 
viscosity was estimated by extrapolating the reduced viscosity value when the 
concentration tends toward 0 by means of a linear regression.  
The Viscosity Average Molecular Weight of polymers was estimated from intrinsic 
viscosity by the Mark-Houwink-Sakurada equation: 
 
[ ]          (2.2) 
 
where [ ] is the intrinsic viscosity,   is the average molecular weight,   and   two 
constants which depend on the solvent and the temperature used (Brandrup , et al., 
1999). 
The operating conditions, i.e. the solvent and   and   values, for the different 
polymers are reported in table 2.2. The molecular weight of the polymers not listed in 
the table was derived from literature data. 
 
Table 2.2. Operating conditions used for each kind of polymer. 
Polymer Solvent K (x10
3
) [dL*g
-1
] α [-] References 
SA NaCl 0.1 M 0.1228 0.963 (Mancini, et al., 1996) 
XG NaCl 0.1 M 0.0017 1.140 (Brandrup , et al., 1999) 
KC NaCl 0.1 M 0.0310 0.950 (Rochas, et al., 1990) 
 
2.3.2 Powder flowability measures 
Flow properties of powders were evaluated determining the Compressibility Index 
and the Hausner Index, which were calculated as follows: 
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              (     )                (2.4) 
 
where    and    are, respectively, the unsettled apparent volume and the final tapped 
volume of the powder.  
   and    were measured according to a FUI XII ed. (F.U.I., 2008) modified method: 
10 g of powder were let flow into a volumetric cylinder leading to    value; then the 
cylinder was tapped 20 times from a specific height (1 cm) and    was calculated.  
Powders of polymers and mixtures polymer/excipients blend used for tablets 
preparation were subjected to the test. Each sample was analyzed three times.  
The flow properties of the powders was evaluated using the scale of flowability 
reported in FUI XII ed (F.U.I., 2008) (table 2.3). 
 
Table 2.3. Scale of flowability (F.U.I., 2008). 
Compressibility Index (CI) [%] Flowability Hausner Index (HI) [-] 
1-10 Excellent 1.00 – 1.11 
11-15 Good 1.12 – 1.18 
16-20 Discrete 1.19 – 1.25 
21-25 Passable 1.26 – 1.34 
26-31 Poor 1.35 – 1.45 
32-37 Very poor 1.46 – 1.59 
>38 Extremely poor > 1.60 
 
2.3.3 Preparation of mucoadhesive tablets 
Tablets were prepared by direct compression of mixtures composed by 60% [w/w] of 
polymer and 40% [w/w] of an excipients blend. The excipients blend was added in 
order to increase the flow properties of the polymers and its composition is reported 
in table 2.4. 
Tablets were prepared using a single punch tablet press (COSALT type, Officina 
CO.STA. S.r.l., Italy) fitted with a flat-faced circular punch (5 mm diameter) (figure 
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2.1). The weight of the tablets ranges from 76 mg to 136 mg and the thickness ranges 
from 3 to 4 mm. 
 
Table 2.4. Excipients blend composition.  
Components Amount [%] 
Ludipress
®
 85 
Microcrystalline Cellulose T1 10 
Magnesium Stearate 3 
Talc 2 
 
 
Figure 2.1. Single punch tablet press. 
 
2.3.4 Tablets crushing strength 
The evaluation of the tablets breaking force or crushing strength was carried out by 
means of a T.A.HDi
®
/250 Texture Analyser (Stable Micro System Ltd, UK) (figure 
2.2) equipped with a cutting probe. During the test, the cutting probe moves with a 
downward rate of 0.1 mm*s
-1
.The instrument starts to acquire data once the trigger 
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force of 0.1 N is reached. The compression force needed for breaking the tablet was 
registered. At least 3 tablets for each type were analysed. 
Data processing was performed by using Texture Expert
®
 software.  
 
          
(A)                                              (B) 
Figure 2.2. T.A.HDi®/250 Texture Analyser (A) with an example of graph obtained from the 
crushing strength test (B). 
 
2.3.5 Evaluation of tablets behavior in aqueous medium 
Since these wet adhesive polymers exhibit their mucoadhesive properties once 
hydrated, the behavior of tablets in aqueous medium has been studied through the 
evaluation of the water uptake capacity and the swelling degree. 
 
 Water Uptake capacity 
The Water Uptake capacity of tablets is the ability of tablets to absorb water and it is 
related to the hydrophilicity of tablets components, especially the polymer. Water 
Uptake capacity of tablets was determined by a gravimetric method. Tablets were 
fixed on a plastic support with cyanoacrylate glue (section (A), figure 2.3) and 
accurately weighed. Tablets were then immersed in a becher containing 30 mL of 
water at room temperature (section (B), figure 2.3). At intervals of 5 minutes for 1 
hour, the tablets were taken out of the incubation medium and accurately weighed 
after removing the excess of water (section (C), figure 2.3). The amount of Water 
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Uptake (WU), expressed as a percentage, was calculated according to the following 
equation: 
   (
     
  
)         (2.5) 
 
where    is the weight of the wet tablet at time t and    is the initial weight of the 
dry tablet. 
The analysis was repeated three times for each formulation.  
 
 
Figure 2.3. Schematic representation of the gravimetric method used to measure tablets WU: 
(A) the dry tablet was weighed and fixed on a plastic support; then the tablet was immersed 
in water (B) and every 5 minutes for 1 hour, it was taken out and accurately weighed after 
removing the excess of water (C). 
 
 Swelling studies 
Swelling studies were performed by means of an image analysis realized by using a 
CMOS Bayer Camera (DBK-61BUC02) with a resolution of 2048x1536, purchased 
from The Imaging Source Europe GmbH (Germany). IC Capture 2.1 (The Imaging 
Source) and Matlab 2010 (The MathWorks Inc.) software were used for images 
acquisition and mathematical analysis, respectively. 
For the analysis, tablets were fixed with a double-sided tape on the black bottom of a 
plastic cubic cell, which was filled with 30 mL of water (section (A), figure 2.4). 
Then tablets were allowed to swell for 1 hour at room temperature and at scheduled 
time intervals (1 minute) an image was captured (section (B), figure 2.4). 
 
 
(A) (B) 
 
(C) 
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Figure 2.4. Schematic representation of the image analysis used to measure tablets swelling: 
(A) dry tablet at time zero and (B) swollen tablet after immersion in water for 60 minutes. 
 
This image was elaborated by the software in order to measure the approximate 
volume of the dosage form using the equation that express the volume of a solid of 
revolution:  
 
   ∫   
  
 
      (2.6) 
 
where   is the volume of the solid of revolution,    is the radius of the solid 
circumference and    is the solid height, as explained in figure 2.5.  
 
 
Figure 2.5. Graphical representation of a solid of revolution. 
 
The Swelling Index (SI) of tablets, expressed as a percentage, was calculated 
according to the following equation: 
(A) (B) 
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   (
     
  
)          (2.7) 
 
where    is the volume of the swollen tablet at time t and    is the initial volume of 
the dry tablet. 
The analysis was repeated three times for each formulation.  
 
2.3.6 Tensile Test for the detection of tablets mucoadhesive properties 
The mucoadhesive performance of tablets was measured by means of a 
T.A.HDi
®
/250 Texture Analyser (Stable Micro System Ltd, UK) equipped with a 
load cell of 250 kg, using the “adhesive test” mode. The tablet was fixed with 
cyanoacrylate glue on the mobile metallic cylindrical probe (6 mm diameter) of the 
instrument, covered with an aluminum foil. The tablet was immersed in 30 mL of 
water for five minutes, the excess of water was removed and then the tablet was 
brought in contact with the mucus substitute fixed on the mucus sliding lower 
platform. The two materials were held in contact for a specific time with a specific 
force and then the probe was removed vertically at a constant upward speed (figure 
2.6).  
 
Figure 2.6. Schematic representation of the tensile test performed in this study: probe with 
hydrated tablet was moved downward (STEP A); hydrated tablet was held in contact with the 
mucus substitute with specified time and force (STEP B); probe was withdrawn at a specified 
rate and the two materials were separated (STEP C) (modified from Thirawong, et al., 2007). 
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The study was carried out at room temperature (25°C) with at least five repeats 
obtained for each sample. 
Data processing was performed by using Texture Expert
®
 software. In particular, the 
force required to detach the tablet from the mucus substitute (maximum detachment 
force) was measured as the peak value (Fmax, [mN]) in the force-time plot, while the 
work of adhesion (Wad, [mN*mm]) was calculated as the area under the force-
distance plot (figure 2.7). 
 
Figure 2.7. A typical plot of force [mN] versus distance [mm] obtained from the 
mucoadhesive test using texture analyser and used for the determination of Wad. 
 
The operating conditions of the procedure used to perform the tensile test are the 
following: 
 tablet pre-hydration time of 5 min; 
 mucus substitute consisting of 30% [w/w] aqueous mucin gel settled in a 
cylindrical cell with a depth of 2 mm and 36 mm diameter; 
 probe speed of 0.2 mm*s-1; 
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 contact force between tablet and mucus substitute of 0.1 N; 
 contact time between tablet and mucus substitute of 60 sec; 
 data acquisition rate, i.e. the rate at which data is stored into the computer 
memory, equal to 50 points*s
-1
. 
 
2.4 Results and Discussion 
 
The study started by selecting four ionic natural polymers, having well-known 
mucoadhesive properties: sodium alginate (SA), xanthan gum (XG), tragacanth gum 
(TG) and k-carrageenan (KC). Powders were characterized by flowability test in 
order to assess their suitability for compression. 
Results are reported in table 2.5, which shows that all polymers have discrete or good 
flow properties and therefore they may be compressed without the necessity to add 
other excipients. However, their compression in pure form was not feasible due to the 
high speed of the single punch tablet press and the high adhesion of polymers to the 
punches. 
 
Table 2.5. Flow properties of polymer powders in terms of Hausner Index, Compressibility 
Index and Flowability, according to the classification of FUI XII ed (F.U.I., 2008). 
Polymer Hausner Index (HI) [-] Compressibility Index (CI) [%] Flowability 
SA 1.24±0.00 19.35±0.00 Discrete 
XG 1.16±0.02 13.85±1.49 Good 
TG 1.18±0.02 15.00±1.50 Good 
KC 1.20±0.02 16.38±1.37 Discrete 
 
For this reason, an excipients blend (Ludipress®, microcrystalline cellulose T1, 
magnesium stearate and talc) was added to each polymer. The final composition of 
powder mixtures used to realize tablets is shown in table 2.6. 
The high percentage of the mucoadhesive polymer was chosen to better discriminate 
the differences between polymers. 
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Table 2.6. Quali-quantitative composition of the mixtures used to prepare tablets. 
Components Amount [%] 
Polymer 60.0 
Ludipress
®
 34.0 
Microcrystalline Cellulose T1 4.0 
Magnesium Stearate 1.2 
Talc 0.8 
 
The resulting mixtures were characterized by flowability test, whose data are reported 
in table 2.7: the addition of the excipients blend further improves or does not alter the 
flow properties of polymer powders, with the exception of KC (figure 2.8). In this 
case flow properties get worse, presumably due to the development of cohesive forces 
during the mixing. 
 
Table 2.7. Flow properties of the different mixtures in terms of Hausner Index, 
Compressibility Index and Flowability, according to the classification of FUI XII ed (F.U.I., 
2008). 
Mixture Hausner Index (HI) [-] Compressibility 
Index (CI) [%] 
Flowability 
SA-Excipients blend 1.19±0.01 16.34±0.88 Discrete 
XG-Excipients blend 1.16±0.01 13.93±0.73 Good 
TG-Excipients blend 1.15±0.01 12.93±0.76 Good 
KC-Excipients blend 1.27±0.02 21.36±1.52 Passable 
Excipients blend 1.08±0.03 7.77±2.28 Excellent 
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Figure 2.8. HI [-] and CI [%] values of the polymers in pure form and in mixture with the 
excipients blend. 
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Polymer mixtures were hence compressed using a single punch tablet press with a 
circular flat punch of 5 mm diameter. The instrument is equipped with sensors for the 
measurement of forces. Therefore it was possible to record the forces involved in the 
process, as shown in figure 2.9. 
 
  
(A)                                                        (B) 
Figure 2.9. Example of graphs obtained from data recorded during the compression process 
of the mixture containing SA; graphs report the force [kN] versus the displacement of the 
punches [mm] (A) and the force [kN] versus time [sec] (B).  
 
For each mixture it is possible to obtain the value of the total work of the upper punch 
(Wtot [J]) necessary to compress the mass, which can be considered as the sum of 
three different contributions: work dissipated in the elastic return of the compressed 
mass (Wel [J]), work dissipated in frictional forces (Wf [J]) and net work of 
compression (Wcomp [J]). Transforming the various contributions as percentages of 
the total work (100%) it is possible to make a comparison of the values obtained with 
the four mixtures. The resulting Wf and Wcomp values are reported in figures 2.10 
and 2.11. In particular, the higher Wf value and the lower Wcomp value obtained for 
mixture containing KC, confirm its poor attitude to be compressed. 
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Figure 2.10. Wf values [%] of the four mixtures. 
 
 
Figure 2.11. Wcomp values [%] of the four mixtures. 
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Tablets were subsequently subjected to technological characterization in order to 
evaluate tablets crushing strength, whose data are reported in figure 2.12. 
 
 
Figure 2.12. Crushing strength (F [N]) of the different tablets. 
 
To compare crushing strength values of the different tablets, it must be considered 
that tablets containing SA, XG and TG present similar weight of 134±4 mg, while the 
weight of KC tablets is equal to 78±2 mg. Thus only a comparison between SA, XG 
and TG tablets may be made and it reveals that tablets containing SA and XG are the 
most resistant.  
Nevertheless, all the tablets prove to be resistant enough to possible subsequent 
manipulations and to the destructive forces present in the gastrointestinal tract 
(Kamba, et al., 2002). Indeed, as reported by Kamba M. et al. (Kamba, et al., 2002), 
the maximum mechanical destructive force of the human stomach is 1.9 N while that 
of the small intestine is 1.2 N. 
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The phenomenon of mucoadhesion is closely related to the extent and rate of polymer 
hydration and swelling in aqueous medium (Thirawong, et al., 2007). As a result, in 
order to obtain the maximum mucoadhesive force it is necessary to reach the 
optimum values of dosage form hydration and swelling, which ensure maximum 
exposure of the docking sites for the bond with mucin and chains interpenetration. 
However, an excessive hydration and swelling can lead to a drastic drop in the 
adhesive strength and cracking of the outer cap of the tablet with unwanted drug loss 
(Baloğlu, et al., 2003). 
In order to investigate tablets behavior in aqueous medium, two characterizations 
were developed: a gravimetric test to assess the water uptake capacity of the dosage 
form and an image analysis test to assess its swelling extent or swelling index. Water 
was chosen as hydration medium since it represents the basic medium for the 
development of a new method and does not involve other possible influencing 
factors. 
Results obtained from the two tests are reported in figures 2.13 and 2.14. 
 
 
Figure 2.13. Water Uptake (WU [%]) values of the different tablets in water. 
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Figure 2.14. Swelling Index (SI [%]) values of the different tablets in water. 
 
The graphs show an analogy between the profiles of water uptake and swelling index, 
for each polymer. 
In particular the figures highlight that: 
 tablets containing KC and XG are able to swell and absorb water to a greater 
extent than the other tablets; 
 comparing tablets containing XG with those containing KC, the kinetics is 
initially faster for KC: weight and volume significantly increase at 5 minutes, 
then it slows reaching a plateau; on the other hand, the kinetics of tablets 
containing XG is quite linear for the entire test; 
 tablets containing TG absorb a lower amount of water than the others. This 
may be due to the chemical structure of TG, composed by a water soluble 
component and a water insoluble one. The presence of the water insoluble 
portion reduces the ability of the polymer to hydrate. 
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To compare the swelling index with the water uptake values the graph shown in 
figure 2.15 was constructed.  
 
 
Figure 2.15. WU % and SI % values at the same time ti of the four formulations. 
 
The graph highlights that there is a relationship between WU and SI: an increase in 
weight corresponds to an increase in volume. Moreover, it shows that tablets 
containing TG, even if they reach a final degree of swelling lower than tablets 
containing XG and KC, they swell faster. This can be explained by the chemical 
structure of tragacanth gum. 
In figure 2.16 is represented a graph of the water uptake/swelling index ratio versus 
time which highlights the relationship between the variation in weight and volume of 
the four tablets once placed in aqueous medium. Indeed swelling may be due not only 
to the absorption of water molecules but also to the expansion of the polymer chains, 
which is certainly favored by hydration but not necessarily related to it in a linear 
manner. 
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Figure 2.16. Values of WU/SI ratio versus time for the four formulations. 
 
For tablets containing TG and SA, the time seems to play a very important role in 
determining the degree of swelling and WU since the ratio WU/SI decreases 
markedly over time. This means that SI increases more than WU, and hence the 
polymer chains tend to expand absorbing a relatively small amount of water. 
Subsequently, the mucoadhesive properties of the tablets were evaluated by tensile 
test with Texture Analyser
®
 using water as hydration medium. 
Several factors could influence the results of the test, such as experimental variables 
(time of pre-hydration, force applied, etc.) or the type of mucous substitute. The use 
of biological substrates derived from animals can lead to poorly reproducible data due 
to the inherent variability of tissues of different animals. Consequently, for a simple 
screening of different mucoadhesive capacity of various polymers may be more 
appropriate to use a standardized and easily available substrate, which also avoids 
animals sacrifice. This substrate is represented by mucin which can be employed in 
form of discs or gel (Khutoryanskiy, 2011; Tamburic & Craig, 1997; Thirawong, et 
al., 2007).  
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To perform the test, a layer of 30% [w/w] aqueous mucin gel, loaded on a Perspex
®
 
cylindrical cell, was used as biological substrate.  
The other experimental variables include: tablet pre-hydration time in aqueous 
medium, pre-test, test and post-test speed of the probe, the contact force of the tablet 
with the mucous substrate and their contact time. 
The values of these parameters were selected on the basis of data reported in 
literature (Thirawong, et al., 2007) and some preliminary analysis. To ensure 
adhesion of the pharmaceutical dosage form, the contact force was set at 0.1 N. This 
value is lower than the mechanical force resulting from peristalsis (Kamba, et al., 
2002) and, at the same time, it guarantees a good sensitivity of the instrument. 
Regarding the contact time, literature reports that an increase of this parameter 
generally leads to an increase in both force and work necessaries to produce the 
detachment of the mucoadhesive system from the substrate. However, some studies 
have shown that an increase in contact time higher than 60 seconds not always entails 
a further increase of the force and work of adhesion. Hence, a contact time of 60 
seconds was adopted for the analysis. The probe pre-test, test and post-test speed have 
been fixed at 0.2 mm*s-1. The last very important parameter is the pre-hydration time 
of the tablet on which depends the degree of hydration of the polymer (Thirawong, et 
al., 2007). After some preliminary analysis, a pre-hydration time of 5 minutes was 
adopted because it allowed to better discriminate the different behavior of the 
polymers. The experimental conditions are summarized in table 2.8. 
 
Table 2.8. Operating conditions used for the development of the mucoadhesive test. 
PARAMETER VALUE 
CONTACT FORCE 0.1 N 
CONTACT TIME 60 sec 
PROBE SPEED 0.2 mm*s-1 
PRE-HYDRATION TIME 5 min 
 
The mucoadhesive performance of the dosage form was evaluated considering the 
maximum detachment force (Fmax) and the work of adhesion (area under the curve of 
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detachment, Wad) (Khutoryanskiy, 2011). Figure 2.17 shows the graphs of Fmax and 
Wad for the four formulations, measured using two different batches of mucin. 
 
Figure 2.17. Values of Fmax (top) and Wad (bottom) of the four systems, considering two 
batches of mucin. 
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The change of the batch of mucin led to a decrease of the absolute value of Fmax and 
Wad for all four systems, except the work of adhesion of the formulation containing 
TG. Nevertheless, the classification of the four polymers according to their 
mucoadhesive ability seems not to change with the second mucin batch. SA seems to 
exhibit the best mucoadhesive properties despite showing the greatest variability. SA 
is followed by KC, and hence TG and XG, which prove to be quite similar. 
Another important factor affecting the mucoadhesive properties of a dosage form was 
determined: the molecular weight of the polymers. It was measured by means of a 
viscosimetric method and the subsequent application of the Mark-Houwink-Sakurada 
equation (Brandrup , et al., 1999). Data are reported in table 2.9.  
 
Table 2.9. Viscosity Average Molecular Weight (  [   ]) of the polymers; TG molecular 
weight was extracted from literature data (Belitz, et al., 2009).  
 SA XG TG KC 
  [kDa] 132 1341 840 407 
 
Finally, a comparison of the mucoadhesive properties of the tablets with the other 
mucoadhesion influencing factors (tablets water uptake and swelling index and 
polymers molecular weight), was made. In table 2.10 are reported the values of the 
average molecular weight (M [kDa]), the water uptake and swelling index at 5 
minutes (pre-hydration time) and 60 minutes and the maximum detachment force 
(Fmax [mN]) and work of adhesion (Wad [mN*mm]) measured using the second mucin 
batch. 
 
Table 2.10. Comparison of the mucoadhesive properties with the influencing factors. 
Polymer M 
[kDa] 
WU5min  
[%] 
SI5min 
[%] 
WU60min  
[%] 
SI60min 
[%] 
Fmax 
[mN] 
Wad 
[mN*mm] 
SA 132 112 102 278 575 390 100 
XG 1341 102 118 613 993 153 20 
TG 840 60 66 194 445 215 39 
KC 407 291 441 839 1666 255 56 
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Results suggest the presence of an inverse proportionality between polymer 
molecular weight and mucoadhesive properties of the dosage form: the lower the 
average molecular weight, the higher the mucoadhesive properties (figure 2.18).  
 
 
Figure 2.18. Relationship between polymer average molecular weight (M [kDa]) and Fmax 
[mN] (graph on the top) or Wad [mN*mm] (graph on the bottom) for the four formulations. 
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For the other parameters, no match was identified.  
Nevertheless, there is a correspondence between the results of WU and SI obtained at 
5 and 60 minutes. This evidence justifies the use of the values of WU and SI at 60 
minutes in the comparison between WU or SI and mucoadhesive properties. 
 
2.6 Conclusions 
In this study different methods for the screening of mucoadhesive polymers were 
developed: 
 a tensile test to detect the mucoadhesive properties of the tablet; 
 a gravimetric method to study the ability of the polymer to adsorb water; 
 an image analysis to detect the ability of the polymer to swell; 
 a viscosimetric method to determine the polymer molecular weight.  
 
The screening suggests that SA owns the best mucoadhesive properties. Moreover 
results highlight that the higher the molecular weight of the polymer, the lower the 
mucoadhesive properties of the dosage form, while the degree of swelling and water 
uptake of the dosage form seems to be not correlated to mucoadhesive properties. 
 Chapter 3 
Formulation of mucoadhesive tablets 
containing a model drug 
 
 
3.1 Introduction 
Oral delivery is the preferred route for drug administration because it is natural, not 
invasive and painless than other traditional routes, first of all intravenous and 
intramuscular injection, which also requires specialized personnel for the 
administration. 
Moreover, the oral route has a large mucosal surface available for drug absorption 
and then for its access to the systemic circulation. 
This feature can be exploited by developing mucoadhesive oral formulations, which, 
adhering to the mucosal surface of the gastrointestinal tract, prolong and improve the 
contact between the active molecule and the mucosal surface and allow to realize a 
drug extended-release. This proves to be very advantageous in the case for example 
of drugs characterized by a narrow absorption window in the intestine, because in this 
way it is possible to prolong the residence time at or before this absorption window. 
However, a lot of drugs are inactivated in the gastro-intestinal tract, due to e.g. the 
stomach pH, the presence of proteolytic or peptidolytic enzymes, and the hepatic 
first-pass effect. From this standpoint, it would be interesting to target a drug directly 
to the intestine, allowing it to circumvent most of the previous drawbacks (Duchêne 
& Ponchel, 1997).  
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3.1.1 Structure and function of the gastrointestinal tract 
The digestive system include the gastrointestinal (GI) tract or alimentary canal, which 
in adults measure 10-12 meters, and the accessory organs of digestion including the 
salivary glands, liver, gallbladder, and exocrine pancreas. In particular, the alimentary 
canal is constituted by a set of hollow organs in communication between them that 
begin with the oral cavity, which, through the isthmus of the fauces, is followed by 
the pharynx, esophagus, stomach and intestines. The latter is divided into two 
portions: small intestine, formed by duodenum, jejunum and ileum, and large 
intestine, consisting of cecum, colon and rectum (Reed & Wickham, 2009; Celotti, 
2002; Pasqualino & Panattoni, 2002).  
The digestive system presents the following functions: to ingest and digest food, 
absorb essential nutrients (carbohydrates, proteins, fats, minerals and vitamins), and 
eliminate waste. Digestion occurs by mechanical and chemical processes. Mechanical 
digestion includes chewing, swallowing, and peristalsis (the method by which food 
moves through the entire gut), and defecation. Chemical digestion is the enzymatic 
breakdown of food in the mouth, stomach, and small intestine. When the partially 
digested food and fluid enter the small intestine, biochemical and enzymes secreted 
by the liver and exocrine pancreas break it down into absorbable monosaccharides, 
amino acids, and fatty acids. These nutrients pass through the small intestine wall into 
blood and lymphatic vessels and are transported to the liver for storage or further 
processing (Reed & Wickham, 2009). 
The wall of the gastrointestinal tract is made by four distinct concentric layers: the 
mucosa, the submucosa, the muscularis externa, and either the adventitia or the serosa 
(figure 3.1) (Reed & Wickham, 2009). 
The mucosa, the innermost layer of the gut wall, lines the entire GI tract and consists 
of epithelium, lamina propria, and muscularis mucosa. The mucosal epithelium is 
differentiated along the GI tract; tissue specialization correlates with the regional 
function of the tract. At the upper and lower ends of the GI tract (the mouth, 
esophagus, and anal canal) the mucosal epithelium is protective and composed of 
stratified squamous epithelial cells. On the other hand, the mucosal epithelium in the 
stomach, small intestine, and colon are composed of simple columnar or glandular 
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epithelial cells. The cells in these regions secrete mucous, enzymes, and other 
biochemicals that either protect the mucosa or aid the digestion (Reed & Wickham, 
2009; Pasqualino & Panattoni, 2002).  
 
 
 
Figure 3.1. Segment of the GI tract illustrating the 4 layers of the GI wall (Reed & Wickham, 
2009). 
 
The epithelial cells are highly dynamic, with a quick turnover (24-72 hours) which 
ensures an effective restoration of the mucosa integrity, and have functions of 
absorption and secretion (mainly mucus); in particular, the secretion of mucus 
ensures the flow of luminal contents and the protection from abrasive agents and 
pathogens. Such protection is also supported by the presence of lymph nodes (Peyer's 
patches) and an abundant population of immune cells habiting the mucosa of the GI 
tract. Throughout the small intestine, at the level of the glandular crypts, Paneth cells 
are also involved in the defense mechanisms of the mucous membrane as they 
produce antibacterial proteins (Celotti, 2002). 
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At the gastric level, the epithelium is lined by mucous cells that produce mucus and 
bicarbonate to avoid destruction by hydrochloric acid. The maintenance of a layer of 
bicarbonate and mucus is essential to protect the gastric wall by the action of the 
proteolytic gastric juice. The activity of mucous cells is controlled by cholinergic and 
mechanical stimulations and by the presence of prostaglandin E, which is produced 
by different type of cells. Prostaglandins also act by increasing the mucosal blood 
flow (which is essential for the continuous production of mucus), by maintaining the 
integrity of intercellular junctions and by stimulating the turnover of epithelial cells in 
response to damage to the mucosa. Several factors inhibit the mucus formation, such 
as the intake of NSAIDs which block the production of prostaglandins (Celotti, 
2002). 
 
3.1.2 Aim 
In this Chapter a mucoadhesive formulation, containing a model drug (sodium 
butyrate) with the intestinal tract as target, has been developed.  
The research started by expanding the range of polymer to be screened, considering 
also two cellulose derivatives with different ionic character: sodium 
carboxymethylcellulose (NaCMC), anionic, while hydroxyethylcellulose (HEC), 
nonionic. The properties of the new polymers were compared to those of the 
polymers previously studied, in order to identify the polymer with the best 
mucoadhesive properties. In this phase the tensile test was optimized in order to 
produce more robust results and get closer to the intestinal physiological conditions 
by changing the hydration medium.  
The polymers with the best mucoadhesive properties were used to prepare tablets 
containing sodium butyrate. Finally, the influence of the amount of polymer on the 
mucoadhesive properties and the drug release was studied.  
 
3.2 Materials  
The following were used: sodium alginate E401 (Satialgine S1100), xanthan gum Ph. 
Eur.-USP, tragacanth gum powder NF18, talc PHARMA USP Ph.Eur., magnesium 
stearate FU-Ph.Eur., microcrystalline cellulose T1 Ph.Eur., calcium phosphate 
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tribasic E341, mannitol for direct compression, potassium phosphate monobasic, 
sodium hydroxide, sodium chloride, all eleven supplied by A.C.E.F. S.p.A. (Italy); 
Ludipress
®
 and Gelcarin GP 911NF K-Carrageenan purchased from BASF The 
Chemical Company (Germany) and IMCD UK LTD (United Kingdom), respectively; 
mucin (from porcine stomach, type II), sodium butyrate 98% and acetonitrile supplied 
by Sigma-Aldrich (USA); hydroxyethylcellulose (Tylose
®
 H 4000 G4 PHA) and 
sodium carboxymethylcellulose (Blanose
®
 cellulose gum 7H3SF, degree of 
substitution 0.80-0.95) supplied by Clariant GmbH (Germany) and Hercules Inc. 
(USA), respectively; phosphoric acid and methanol HPLC Gradient Grade purchased 
from Acros Organics (Belgium) and J.T. Baker
®
 (Netherlands), respectively. 
In all preparations of solutions and buffers, deionized water was used. 
Characteristics, properties and applications of the new mucoadhesive polymers are 
described in detail in table 3.1. 
 
Table 3.1. Properties and applications of the new polymers used in the study.  
Polymers Properties Applications 
Hydroxyethylcellulose 
(Tylose® H 4000 G4 PHA) 
Partially substituted 
poly(hydroxyethyl) ether of 
cellulose. 
 
(Rowe, et al., 2006) 
 
Sodium Carboxymethylcellulose 
(Blanose® Cellulose Gum 7H3SF) 
Sodium salt of a polycarboxymethyl 
ether of cellulose. 
 
 Nonionic, water-soluble and 
hygroscopic polymer, available 
in several grades that vary in 
viscosity and degree of 
substitution (2-20000 mPa*s for 
a 2% [w/v] aqueous solution). 
 A 1% [w/v] aqueous solution 
owns a pH of 5.5-8.5. 
 Practically insoluble in most 
organic solvents. 
 
 
 
 
 
 Hygroscopic polymer, 
practically insoluble in acetone, 
ethanol (95%), ether, and 
toluene; the aqueous solubility 
varies with the degree of 
substitution (DS). 
 Molecular weight ranges from 
90-700 kDa. 
 DS of 0.80-0.95; viscosity of a 
 It is used as a thickening agent 
in ophthalmic and topical 
formulations, as a binder and 
film-coating agent for tablets. 
 Hydroxyethylcellulose 
hydrogels may also be used in 
various delivery systems. 
 
 
 
 
 
 
 
 
 It is widely used in oral and 
topical pharmaceutical 
formulations, mainly for its 
viscosity-increasing properties. 
 It may also be used as a tablet 
binder and disintegrant, and to 
stabilize emulsions. 
 Its mucoadhesive properties are 
used in various pharmaceutical 
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(Rowe, et al., 2006) 
 
1% aqueous solution of 1000-
2800 mPa*s at 25°C (Brookfield 
LVF, spindle n°3, 30 rpm). 
 High concentrations, usually 3-
6%, of the medium-viscosity 
grade are used to produce gels. 
formulations to localize and 
modify the release kinetics of 
active principles applied to 
mucous membranes. 
 Moreover, it can be used to 
prevent post-surgical tissue 
adhesions, for bone repair and 
to realize dermatological 
patches. 
 
 
3.2.1 Sodium Butyrate 
Sodium butyrate (SB) was chosen as a model drug since it acts locally in the gastro-
intestinal tract and it is therefore suitable for the administration through this type of 
pharmaceutical dosage form. 
Sodium butyrate is the sodium salt of butyric acid (CH3CH2CH2COO
-
 Na
+
), a short-
chain fatty acid characterized by a solubility in water of 100 mg/mL, measured at 
20°C. It is present in nature as a component of the milk and its derivatives fat 
fractions. In humans it is a metabolite of intestinal bacteria, an important energy 
source for the intestinal epithelial cells and it plays a key role in the homeostasis of 
the gastrointestinal tract. The largest resource of sodium butyrate in the human colon 
derives from carbohydrates introduced into the body with food. 
The functions of the butyric acid in the intestine are: 
 stimulation of the turnover and the physiological maturity of colonocytes and 
key role in maintaining the mucosa integrity and in repairing the intestinal 
lesions; 
 stimulation of the reabsorption of water and sodium in the colon (useful in 
presence of diarrhea of infectious origin or induced by antibiotics); 
 aid in lowering the intestinal pH and hence creation of an unfavorable 
environment for the development of pathogenic bacteria; 
 stimulation of the repairing and healing processes of the rectal mucosa, thus 
representing a potential effective approach in the prevention of acute and 
chronic damages resulting from radiotherapy. 
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Consequently, products containing sodium butyrate are indicated in the treatment of 
some disorders of the gastrointestinal tract as the following: 
 spastic, infectious or antibiotic-associated colitis; 
 irritable bowel syndrome, diarrhea, diverticulitis; 
 chronic inflammatory diseases, such as Crohn’s disease (Cummings, 1981). 
 
3.3 Methods 
3.3.1 Determination of intrinsic viscosity and Viscosity Average Molecular 
Weight of polymers 
Viscosity average molecular weights of NaCMC and HEC were measured using the 
method described in Section 2.3.1. 
The operating conditions, i.e. the solvent used and   and   values, for the new 
polymers are reported in table 3.2.  
 
Table 3.2. Operating conditions used for HEC and NaCMC. 
Polymer Solvent K (x10
3
) [dL*g
-1
] α [-] References 
HEC Water 0.0953 0.870 (Brandrup , et al., 1999) 
NaCMC NaOH 0.5 M 0.5370 0.730 (Eremeeva & Bykova, 
1998) 
 
3.3.2 Powder flowability measures 
Flow properties of powders (polymers in pure form and in mixture) were evaluated 
by means of the method described in Section 2.3.2.  
 
3.3.3 Preparation of mucoadhesive tablets 
Tablets were prepared by direct compression of the powders, using a single punch 
tablet press (COSALT type, Officina CO.STA. S.r.l., Italy) fitted with a flat-faced 
circular punch (5 mm diameter). The weight of the tablets ranges from 78 mg to 136 
mg and the thickness ranges from 3 to 4 mm. 
The composition of the placebo tablets is reported in table 3.3. 
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Table 3.3. Quali-quantitative composition of the mixtures used to prepare the placebo 
tablets. 
 
Components Amount [%] 
Polymer 60.0 
Ludipress
®
 34.0 
Microcrystalline Cellulose T1 4.0 
Magnesium Stearate 1.2 
Talc 0.8 
 
The formulation of tablets containing sodium butyrate consists in 30, 45, 60% [w/w] 
of polymer (SA or NaCMC), 20% [w/w] of sodium butyrate, 15% [w/w] of an 
excipients blend (table 2.4, Section 2.3.3); the formulation was completed with the 
addition of varying amounts of a water-soluble excipient (mannitol, MA) or a water-
insoluble excipient (calcium phosphate, CP). 
 
3.3.4 Technological characterization of tablets  
Tablets were characterized by uniformity of mass test and tablet crushing strength 
determination.  
The evaluation of the uniformity of mass of single-dose preparations was performed 
according to F.U.I XII ed (F.U.I., 2008): weigh individually 20 units taken at random, 
and determine the average mass. Not more than 2 of the individual masses deviate 
from the average mass by more than the percentage deviation shown in table 3.4 and 
none deviates by more than twice that percentage. 
 
Table 3.4. Values of the uniformity of mass of single-dose preparations assay for tablets 
(F.U.I., 2008). 
Dosage form Average mass Percentage deviation 
Tablets  
(uncoated and 
film-coated) 
80 mg or less 10 
More than 80 mg and less than 250 mg 7.5 
250 mg or more 5 
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The evaluation of tablets breaking force or crushing strength was carried out by 
means of the same method reported in Section 2.3.4.  
 
3.3.5 Evaluation of tablets behavior in aqueous medium 
The evaluation of tablets behavior in aqueous medium was performed by measuring 
the water uptake and swelling of tablets with the methods described in Section 2.3.5. 
Subsequently, these methods were optimized by changing the aqueous medium 
moving from deionized water to phosphate buffer pH 6.8 (according to F.U.I., 2008), 
in order to simulate the intestinal conditions.  
Moreover, for placebo tablets another parameter was measured: tablets wettability, 
which represents a necessary condition for mucoadhesion to occur. This parameter 
was evaluated by means of the determination of solid-liquid contact angle. 
 
 Wettability and Contact Angle 
The wettability assessment of tablets was based on the determination of the solid-
liquid contact angle (Lazghab, et al., 2005).  
The wettability of a solid may be defined as the tendency more or less marked of a 
solid to be wetted by a liquid; hence, it can be expressed as a function of the contact 
angle arising between solid and liquid after deposition of a liquid drop on a solid 
surface, such as the base of a tablet: the higher the affinity between solid and liquid, 
the smaller the contact angle between them (Colombo, et al., 2004). In particular, in 
the case of angles between 0° and 90°, the solid is readily wettable by the liquid, 
while in the case of angles between 90° and 180° is hardly wettable (Colombo, et al., 
2004). 
The measure of the contact angle between tablet and water was realized using an 
image analysis called “drop shape analysis”: the contact angle (θ) was obtained from 
the image of a sessile drop and it corresponds to the angle arising from the 
intersection point (3-phase solid-liquid-vapor contact point) between the drop base 
line and the drop shape line (figure 3.2).  
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Figure 3.2. Example of image of a sessile drop (the drop profile fitting [Tangent-1] is 
highlighted in green while the base line of the drop on the solid surface is represented in 
pink). 
 
For the analysis, the Drop Shape Analyser - DSA 30S (KRŰSS GmbH, Germany) 
was used, as represented in figure 3.3. 
 
Figure 3.3. DSA 30S, the instrument used for contact angle measures. 
 
The instrument is equipped with a dosing system and a sample holder placed between 
a halogen lamp and a camera. Using the dosing syringe a drop of water of 5 L was 
created and after deposited on the flat portion of the tablet (base). The camera 
recorded a video of the whole process and then the processing of the individual 
frames was performed by means of the software DSA4 2.0.: once the operator defines 
the baseline, the software recognizes and outlines the drop profile which is 
subsequently fitted using a selected mathematical model. In this study a geometrical 
asymmetrical model (ellipse method “Tangent-1”) was selected. This method 
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approximates the drop shape to an ellipse, as shown in figure 3.2. The processing of 
the video frames was limited to the first 3.5 seconds from the deposition of the 
droplet on the tablet. For each frame the software measured both left and right contact 
angles and calculated the average value of the two. Results represent the mean 
contact angle values obtained analyzing six placebo tablets for type of polymer. 
 
3.3.6 Optimization of the tensile test 
The assessment of mucoadhesive properties is fundamental for the production of 
novel drug delivery systems (Khutoryanskiy, 2011). Although many methods have 
been developed for studying mucoadhesion, pharmacopoeial methods and standard 
apparatus are not available so far; consequently, an inevitable lack of uniformity 
between test methods has arisen (Shaikh, et al., 2011; Woertz, et al., 2013). Therefore 
the development of at least robust and reproducible detection methods must assume a 
central role in this kind of research.  
To pursue this goal we decided to optimize the tensile test in order to get closer to 
physiological conditions and verify precision and accuracy of the single data.  
The optimization of the tensile test (described in Section 2.3.6) was carried out firstly 
replacing water as tablet hydration medium with phosphate buffer pH 6.8 to simulate 
the physiological conditions of the intestine. 
Then the following operating parameters were changed: 
 contact force applied between the mucus substitute and the tablet of 0.4 N, 
instead of 0.1 N; 
 contact time between the mucus substitute and the tablet equal to 15 sec, 
instead of 60 sec; 
 data acquisition rate, i.e. the rate of data storage into the computer memory, 
equal to 200 points*s
-1
 instead of 50. 
Finally, the mucus substitute consisting of a 30% [w/w] aqueous mucin gel was 
replaced with mucin discs (Baloglu, et al., 2011) (13 mm diameter and 3 mm depth) 
prepared by the compression of 500 mg mucin in a single punch press (Atlas Manual 
15T Hydraulic Press, SPECAC LTD., UK) using a compression force of 10 tons. For 
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the tensile test the mucin disc was fixed with cyanoacrylate glue on an aluminum foil 
and it was hydrated in the same way of tablets (phosphate buffer 6.8 for 5 minutes 
before starting the tensile test) (figure 3.4). 
 
 
 
 
 
 
 
Figure 3.4. Dry mucin disc (A) and mucin disc after 5 minutes of hydration (B). 
 
The tensile test was performed using the three different procedures described in detail 
in table 3.5. 
 
Table 3.5. Three different procedures of the adhesive test (all performed with phosphate 
buffer pH 6.8 as hydration medium). 
 
Procedure 
Mucus 
substitute 
Contact Force 
[N] 
Contact Time 
[sec] 
Data aquisition 
rate [points*s
-1
] 
1 mucin gel 0.1 60 50 
2 mucin gel 0.4 15 200 
3 mucin disc 0.4 15 200 
 
In this way it was possible to verify the correspondence of the results obtained using 
the three different procedures and hence the accuracy of the experimental data. 
For the other technical specifications (temperature, etc.), see Section 2.3.6. For each 
polymer were performed five repetitions. 
The mucoadhesive properties of tablets containing sodium butyrate were evaluated 
using the procedure 3.  
 
 
(A) (B) 
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3.3.7 Dissolution test 
Tablets containing sodium butyrate were subjected to in vitro drug dissolution tests, 
performed according to FUI XII ed. (F.U.I., 2008), with a dissolution apparatus 2 
(Sotax AT7 Smart, Sotax, Switzerland) at 100 rpm. The dissolution tests were carried 
out at 37 ± 0.5 °C in 900 mL of simulated intestinal fluid (phosphate buffer pH 6.8) 
as dissolution medium. During the release studies, 1 mL of dissolution medium 
sample was removed and filtered; SB quantification was performed using the HPLC 
technique reported in Section 3.3.8. The volume removed was replaced each time 
with fresh medium. Results are averaged from three replicated experiments. 
 
3.3.8 Analytical method for the determination of sodium butyrate 
The quantitative determination of sodium butyrate was made by HPLC analysis 
(model: 1220 Infinity LC, Agilent Technologies, USA) using a UV/VIS detector. For 
the analysis, a mixture of phosphoric acid pH 2.38 aqueous solution and acetonitrile 
(ratio 90:10) was used as mobile phase. 
The analytical conditions of the method are the following: 
 Agilent ZORBAX RX-C18 column (5 m, 4.6*250 mm, 80 Ǻ); 
 flow rate of the mobile phase 1 mL/min; 
 detection wavelength of 210 nm. 
Using these conditions the sodium butyrate retention time is about 9.50 minutes. 
Figure 3.5 reports an example of sodium butyrate chromatogram. 
 
 
 
Figure 3.5. Example of sodium butyrate chromatogram. 
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3.4 Results and Discussion 
The aim of this part of the study was the development of mucoadhesive tablet 
containing SB as model drug. In order to achieve this purpose the range of polymers 
considered in the previous chapter was further increased. In particular, two 
semisynthetic cellulose derivatives with different ionic characteristic were included: 
hydroxyethylcellulose (HEC), nonionic, and sodium carboxymethylcellulose 
(NaCMC), anionic.  
The new polymers were subjected to the flowability test reported in Chapter 1. The 
Hausner Index and the Compressibility Index of the polymers in pure form and in 
mixture (excipients blend: Ludipress
®
, microcrystalline cellulose T1, magnesium 
stearate and talc) were evaluated according to FUI XII. ed. (F.U.I., 2008). The 
flowability test showed that the addition of the excipients blend to the new polymers 
further improves or does not change the powder flowability (table 3.6).  
 
Table 3.6. Results of the flowability test of the new polymers. 
Powder Hausner Index 
(HI) [-] 
Compressibility Index  
(CI) [-] 
Flowability 
HEC 1.30±0.01 23.16±0.76 Passable 
HEC-Excipients blend 1.16±0.02 13.71±1.69 Good 
NaCMC 1.18±0.01 15.53±0.46 Discrete 
NaCMC-Excipients blend 1.19±0.02 16.18±1.47 Discrete 
 
Mixtures containing 60% [w/w] of polymer and 40% [w/w] of excipients blend are 
compressed in order to produce tablets which were then characterized by the test of 
uniformity of mass (F.U.I., 2008) and the crushing strength test.  
The force necessary to break the tablets is equal to 42.96±2.93 N for HEC and 
68.01±4.24 N for NaCMC. These values confirm that tablets are enough resistant to 
possible subsequent manipulations and to the destructive forces present in the 
gastrointestinal tract, which are equal to 1.9 N in the stomach and 1.2 N in the small 
intestine (Kamba, et al., 2002). 
The next step was to evaluate the ability of the new polymers to hydrate and swell in 
water in terms of water uptake (WU) and swelling index (SI), as shown in figure 3.6. 
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Figure 3.6. Values of WU [%] (top) and SI [%] (bottom) of the new polymers in water. 
 
The graphs show that tablets containing NaCMC swell and absorb water in larger 
amounts compared to those of HEC and also in this case a good linearity exists 
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between WU and SI: an increase in weight corresponds to an increase in volume, as 
highlighted in figure 3.7. 
 
 
Figure 3.7. Relationship between water uptake (WU [%]) and swelling index (SI [%]) for the 
tablets containing NaCMC and HEC. 
 
The viscosity average molecular weight of NaCMC and HEC was determined by 
means of the same method used for the other polymers. NaCMC exhibits an average 
molecular weight of 519 kDa while HEC of 467 kDa. 
The mucoadhesive properties of the tablets containing NaCMC and HEC were 
evaluated in terms of maximum detachment force (Fmax) and work of adhesion (Wad) 
using the tensile test (procedure 1 of table 3.5). Results reported in figures 3.8 and 3.9 
show that tablets containing HEC and NaCMC seem to exhibit similar mucoadhesive 
properties. However, comparing results obtained for all the polymers, sodium 
alginate remains the polymer with the best mucoadhesive properties. 
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Figure 3.8. Values of Fmax of the all the tablets (for SA, XG, TG and KC the results 
corresponding to the second mucin batch were considered). 
 
 
Figure 3.9. Values of Wad of all the tablets (for SA, XG, TG and KC the results corresponding 
to the second mucin batch were considered). 
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In order to highlight the presence of a relationship between the mucoadhesive 
properties and the other evaluated polymer properties, some comparison were 
performed (table 3.7). 
 
Table 3.7. Comparison of molecular weight (M), water uptake (WU) and swelling index (SI) 
at 5 and 60 min, maximum detachment force (Fmax) and work of adhesion (Wad) for all the 
tablets containing different polymers (the mucoadhesive properties of tablets containing SA, 
XG, TG and KC are referred to the second mucin batch). 
Polymer M 
[kDa] 
WU5min  
[%] 
SI5min 
[%] 
WU60min  
[%] 
SI60min 
[%] 
Fmax 
[mN] 
Wad 
[mN*mm] 
SA 132 112 102 278 575 390 100 
XG 1341 102 118 613 993 153 20 
TG 840 60 66 194 445 215 39 
KC 407 291 441 839 1666 255 56 
NaCMC 519 91 147 401 914 243 62 
HEC 467 51 161 188 573 243 55 
 
Data confirm the presence, as seen in Chapter 2, of an inversely proportional 
relationship between polymer molecular weight (M) and mucoadhesive properties 
(Fmax and Wad) of the tablets (figures 3.10 and 3.11): the lower the average molecular 
weight, the higher the mucoadhesive properties. 
As highlighted previously, for the other parameters no evident match was found. 
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Figure 3.10. Relationship between polymers molecular weight (  [   ]) and the 
mucoadhesive properties (Fmax [mN]) of the tablets in water. 
 
 
Figure 3.11. Relationship between polymers molecular weight (  [   ]) and the 
mucoadhesive properties (Wad [mN*mm]) of the tablets in water. 
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In order to develop a dosage form with intestinal target, the hydration medium was 
changed to get closer to the physiological conditions: water was replaced with 
phosphate buffer pH 6.8 and the three characterizations (water uptake, swelling index 
and tensile test) were repeated for all the tablets, except those containing KC. These 
tablets, indeed, disintegrate rapidly in phosphate buffer as κ-carrageenan dissolves in 
aqueous medium in presence of sodium ions (Rowe, et al., 2006). This hypothesis 
was confirmed by the immediate disintegration of a tablet containing KC placed in a 
0.9% sodium chloride solution. 
Results of water uptake and swelling index pointed out that there were no significant 
differences in polymers behavior in the two solvents, with the exception of tablets 
containing XG. Indeed, in this case, WU and SI in buffer are considerably lower than 
those obtained in water (figures 3.12 and 3.13). This behavior may be correlated with 
the fact that the solubility of XG is influenced by presence of salts (Rowe, et al., 
2006).  
 
 
Figure 3.12. WU [%] profiles of tablets containing XG in water and in phosphate buffer pH 
6.8. 
0
100
200
300
400
500
600
700
0 10 20 30 40 50 60 70
W
U
 [
%
] 
Time [min] 
water
buffer
Chapter 3                                                                                                                   71 
 
 
 
Figure 3.13. SI [%] profiles of tablets containing XG in water and in phosphate buffer pH 
6.8. 
 
Swelling index and water uptake profiles of all the polymers are reported in figures 
3.14 and 3.15.  
 
 
Figure 3.14. WU [%] profiles of all the polymers in phosphate buffer pH 6.8. 
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Figure 3.15. SI [%] profiles of all the polymers in phosphate buffer pH 6.8. 
 
Comparing the WU and SI values obtained using phosphate buffer as medium, it is 
possible to note that also in this case an increase in water uptake produces an increase 
in volume, as shows in figure 3.16. 
 
From figure 3.16 polymers can be divided into two groups depending on their ability 
to adsorb water and swell. In particular, the ratio between swelling index and water 
uptake can be used to express the swelling ability of a polymer: the lower the 
swelling ability, the lower the swelling of the polymer corresponding to a certain 
level of water uptake. Consequently, SA and NaCMC exhibit the lower swelling 
ability.  
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Figure 3.16. Relationship between WU [%] and SI [%] in phosphate buffer 6.8 of the 
different systems. 
 
The mucoadhesive test performed in buffer revealed that the polymers having the 
higher mucoadhesive properties in terms of Fmax and Wad are those presenting the 
lower swelling ability: SA and NaCMC (figures 3.17-3.18). It therefore seems to 
exist a relationship between mucoadhesion and water uptake/swelling, not observed 
before with the results obtained in water.  
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Figure 3.17. Fmax [mN] values of all tablets in phosphate buffer pH 6.8. 
 
 
Figure 3.18. Wad [mN*mm] values of all tablets in phosphate buffer pH 6.8. 
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In order to confirm these observations it was decided to further optimize the tensile 
test to make data more robust. The wettability of the tablets was also investigated in 
order to clear the behavior of the tablets in aqueous medium.  
 
For the tensile test some operating parameters were changed in order to obtain more 
precise results and decrease the background noise of the instrument: 
- contact force of 0.4 N; 
- contact time of 15 sec; 
- data acquisition rate of 200 points*s-1. 
The experiments in buffer were then repeated for all systems considered (procedure 2 
of table 3.5). 
Subsequently, it was decided to introduce a further modification to the method: the 
mucin gel was replaced with mucin discs (Baloglu, et al., 2011), realized by means of 
direct compression of powders. The experiments in buffer were then repeated for all 
the tablets, using the new experimental parameters and the mucin disc (procedure 3 of 
table 3.5). 
The comparison between the results obtained with the three different procedures is 
reported in figure 3.19. 
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Figure 3.19. Results of the tensile test, in terms of Fmax and Wad, performed using the three 
different procedures. 
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The graphs show that the values of maximum detachment force and work of adhesion 
assume the same trend with all three procedures: this observation confirm the 
accuracy of the data. Since the results obtained with the different procedures are 
comparable, the choice of the substrate to continue the study and the suitable 
operating conditions has been made considering the standard deviation and the 
working time. In particular, the procedure 3 allows a reduction of both the working 
time necessary to prepare the substrate and the data standard deviation; consequently, 
it was chosen to continue the study.  
According to studies reported in literature (Colombo, et al., 2004; Lazghab, et al., 
2005), the water wettability of the tablets has been studied by measuring the contact 
angle arising from the deposition of a drop of water on the tablet. 
Figure 3.20 shows the contact angle values of the first 3.5 seconds after the 
deposition of the drop of water on tablets containing the various polymers. A 
horizontal line divides the values of angle less than 90°, expression of good 
wettability, from the values of angle between 90° and 180°, expression of poor 
wettability. 
 
 
Figure 3.20. Average contact angle (CA [deg]) between tablets and water over time [sec]. 
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To make a comparison of the contact angle values of the various tablets, it is 
necessary to make some assumptions. 
The contact angle is defined as the angle that arises when a balance between the 
cohesive force, that holds together the particles of liquid, and the adhesive strength 
between the liquid molecules and the solid surface, is established. However, in the 
time elapsed between drop deposition and measurement of the angle, a series of 
unwanted time-dependent phenomena, such as absorption or erosion, may grow. 
Thus, considering the contact angle values corresponding to 0.3 seconds after drop 
deposition (sufficient time for the equilibrium to be established in the absence of 
time-dependent phenomena), the non-ionic polymer HEC shows a value of contact 
angle higher than 90°, unlike other polymers; this is justified by its nature (nonionic). 
HEC is followed by TG, probably due to its water-insoluble component, and then by 
the other ionic polymers, presenting lower values of contact angles. Nevertheless, 
results are consistent with the values of WU and SI in water at 60 minutes, equal to 
those performed in buffer, except XG.  
In order to confirm that the different behavior of XG in buffer is time-dependent, the  
buffer wettability of XG was studied and results concerning both solvents are 
compared in figure 3.21.  
Since contact angle values obtained with the two solvents are comparable, it is 
possible to state that the influence of the presence of salts on XG behavior is time-
dependent and hence does not affect XG wettability. 
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Figure 3.21. Average contact angle (CA [deg]) between XG tablets and water or buffer, over 
time [sec]. 
 
Finally, comparing the molecular weights of all polymer with their mucoadhesive 
properties (Fmax and Wad) in phosphate buffer 6.8 (figures 3.22) it is possible to 
confirm the inversely proportional relationship previously observed: the higher the 
average molecular weight of the polymer the lower the mucoadhesive properties (Fmax 
and Wad). 
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Figure 3.22. Relationship between polymers molecular weight (  [   ]) and the 
mucoadhesive properties (Fmax [mN] or Wad [mN*mm]) of the tablets evaluated using 
procedure 3 and phosphate buffer pH 6.8. 
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From the results, two polymers were selected in order to continue the study: SA and 
NaCMC. These polymers were used to formulate tablets containing a model active 
pharmaceutical ingredient (API) and assess how these polymeric matrices could 
influence the API release. Sodium butyrate (SB) was chosen as model drug. It 
presents a water solubility of 100 mg/mL and it is used as adjuvant in the treatment of 
intestinal disorders, for which the formulation in mucoadhesive tablets can be 
advantageous. Tablets with increasing amounts of polymer were prepared in order to 
evaluate the influence of the different amount of polymer on the mucoadhesive 
properties of the dosage form and on the API release.  
The formulations evaluated consist in 30, 45, 60% [w/w] of polymer (SA or 
NaCMC), 20% [w/w] of sodium butyrate, 15% [w/w] of excipients blend; the 
formulations were completed with the addition of a water-soluble excipient 
(mannitol, MA) or a water-insoluble excipient (calcium phosphate, CP). Table 3.8 
shows the formulations composition and the related flowability results. 
 
Table 3.8. Hausner Index, Compressibility Index and flowability of the various mixtures 
formulated, according to FUI XII ed. (F.U.I., 2008). 
Polymer 
Amount of 
polymer 
[%] 
Excipient 
Hausner 
Index [-] 
Compressibility 
Index [%] 
Flowability 
NaCMC 30 MA 1.18±0.01 15.15±0.10 Good 
NaCMC 45 MA 1.21±0.01 17.65±0.10 Discrete 
NaCMC 60 MA 1.21±0.01 17.14±0.10 Discrete 
SA 30 MA 1.23±0.01 18.56±0.30 Discrete 
SA 45 MA 1.24±0.02 19.79±1.34 Discrete 
SA 60 MA 1.29±0.03 22.55±1.70 Passable 
NaCMC 30 CP  1.22±0.04 18.02±2.65 Discrete 
NaCMC 45 CP 1.31±0.05 23.48±2.65 Passable 
NaCMC 60 CP 1.25±0.04 20.15±2.32 Discrete 
SA 30 CP 1.26±0.05 20.74±3.31 Discrete 
SA 45 CP 1.16±0.04 13.89±3.47 Good 
SA 60 CP 1.19±0.03 16.03±2.28 Discrete 
 
As highlighted in the table, mixtures possessed an almost discrete flowability; it was 
therefore possible to realize the tablets, which have been characterized in terms of 
crushing strength and uniformity of mass. Results showed that tablets presented good 
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strength (values higher than 20 N) (table 3.9) and they complied with the Uniformity 
of mass requirements (F.U.I., 2008). 
 
Table 3.9. Average Mass and Percentage Deviation of the tablets. 
 
Polymer 
Amount of 
polymer 
[%] 
Excipient 
Average 
Mass [mg] 
Percentage 
Deviation 
Crushing 
Strength 
[N] 
NaCMC 30 MA 118.6±1.8 1.52 21.88±2.51 
NaCMC 45 MA 119.2±0.9 0.76 22.52±2.36 
NaCMC 60 MA 114.8±1.4 1.22 23.03±2.10 
SA 30 MA 118.5±1.9 1.60 31.64±2.33 
SA 45 MA 115.3±2.4 2.08 34.73±2.48 
SA 60 MA 115.3±1.8 1.56 38.78±2.65 
NaCMC 30 CP 110.8±4.2 3.79 23.67±5.10 
NaCMC 45 CP 131.7±1.6 1.21 47.06±7.29 
NaCMC 60 CP 121.5±0.6 0.49 51.19±7.57 
SA 30 CP 108.3±2.7 2.49 44.83±8.74 
SA 45 CP 129.3±2.7 2.09 61.86±8.35 
SA 60 CP 132.3±4.5 3.40 78.44±6.63 
 
Subsequently, the tablets water uptake and swelling index were measured in 
phosphate buffer pH 6.8. Results of the water uptake test are reported in figures 3.23 
and 3.24, which show that an increase of the amount of polymer corresponds to an 
increase of water uptake. This matches the fact that the higher the amount of polymer, 
the higher the number of functional groups available to form hydrogen bonds and 
thus the system hydrophilicity. 
Furthermore, the tablets containing NaCMC absorb a higher amount of medium with 
those containing SA. It is also possible to note that tablets containing CP absorb 
larger amount of water than those containing MA. 
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A)                                                                   B) 
Figure 3.23. Water Uptake profiles of the tablets containing SA 30, 45, 60% and MA (A) or 
CP (B). 
 
 
A)                                                                   B) 
 
Figure 3.24. Water Uptake profiles of the tablets containing NaCMC 30, 45, 60% and MA 
(A) or CP (B) 
 
For tablets containing MA as excipient, the swelling index depends on the amount of 
polymer (figures 3.25 A and 3.26 A); in particular, the greater the amount of polymer, 
the higher the amount of chains available to form the network.  
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A)                                                                   B) 
Figure 3.25. Swelling Index profiles of the tablets containing SA 30, 45, 60% and MA (A) or 
CP (B) 
 
 
A)                                                                   B) 
Figure 3.26. Swelling Index profiles of the tablets containing NaCMC 30, 45, 60% and MA 
(A) or CP (B) 
 
Tablets containing CP show an opposite trend (figures 3.25 B and 3.26 B): the lower 
the polymer percentage, the higher the swelling and thus the larger is the mesh 
network. As a consequence, in presence of large mesh size the CP is not retained in 
the polymer network and water further penetrates into the structure promoting the 
swelling.  
Nevertheless, tablets containing CP swell more than those containing MA. In the case 
of MA, a lower amount of water is available for the polymer swelling due to the 
solubilization of the water-soluble excipients.  
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Subsequently, the mucoadhesive properties in phosphate buffer pH 6.8 were 
evaluated by means of the procedure 3 of the tensile test (described in table 3.5). Data 
reported in figures 3.27 and 3.28 highlight that there are no significant differences on 
the mucoadhesive ability of the two polymers. Results show that, with both polymers, 
the tablets containing CP exhibit better mucoadhesive properties than those with MA; 
the presence of MA may reduce the hydration of the polymer, which is an important 
condition for mucoadhesion. It is evident, instead, the difference between the tablets 
containing increasing amounts of polymer: with increasing the percentage of polymer 
in the formulation, a gradual increase of the mucoadhesive capacity occurs. 
 
 
Figure 3.27. Results of the tensile test in terms of Fmax [mN]. 
 
 
Figure 3.28. Results of the tensile test in terms of Wad [mN*mm]. 
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In order to verify how the type and amount of polymer may influence the release of 
SB from the tablets, dissolution tests in simulated intestinal fluid (phosphate buffer 
pH 6.8) were performed. 
The release profiles are shown in figures 3.29-3.32. Data show that there are no 
significant differences between the tablets realized with increasing concentrations of 
polymer. 
This may be due to the high solubility of the drug (approximately 100 mg/mL at 
20°C); in the case of molecules very soluble in water, the release is mainly controlled 
by the diffusion of the molecule through the polymer gel layer, while for poorly 
soluble drugs it mainly depends on the dissolution and the relaxation of the polymer 
chains. 
Comparing the two polymers, tablets with NaCMC gave a slower release than those 
containing SA. This behavior may be attributed to the capacity of NaCMC to form a 
gel layer more viscous than SA. This agrees with the viscosity values of 0.5% [w/w] 
water dispersions of the two polymers, which are equal to 199 mPa*s for NaCMC 
and 100 mPa*s for SA (measurements carried out at 20°C with a Brookfield 
viscosimeter VT7R, impeller R2, 30 rpm). 
Moreover, for tablets containing NaCMC and CP, the release rate depends on the 
amount of polymer: the lower the amount of polymer the faster the drug release. 
These data fit with the results obtained in the swelling study.  
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Figure 3.29. Dissolution profiles of tablets containing MA and SA. 
 
 
Figure 3.30. Dissolution profiles of tablets containing MA and NaCMC. 
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Figure 3.31. Dissolution profiles of tablets containing CP and SA. 
 
 
Figure 3.32. Dissolution profiles of tablets containing CP and NaCMC. 
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3.5 Conclusions 
In this phase of the research the number of polymers studied was expanded and the 
tensile test was optimized.  
Among the studied properties of the polymer and the dosage form, the most important 
one for mucoadhesion seems to be the polymer molecular weight. 
Two polymers having the best mucoadhesive properties (SA and NaCMC) were 
selected to continue the study and sodium butyrate was chosen as model drug.  
Formulations containing different amounts of polymers were tested in order to 
identify the relationship between polymer concentration and mucoadhesion.   
The results showed that the higher the amount of polymer, the greater the 
mucoadhesive properties. The dissolution profiles of SB seem to be not significantly 
influenced by the formulation variables since the drug is very soluble in water.
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 Chapter 4 
Development of sustained-release 
mucoadhesive tablets  
 
 
4.1 Introduction 
4.1.1 Aim 
The aim of this study was to develop sustained-release mucoadhesive tablets 
containing sodium butyrate or mesalazine using the Design of Experiments 
techniques (DoE). 
For this purpose the range of polymers was further expanded including a polymer 
with well-known extended-release properties, i.e. hydropylmethylcellulose. 
 
4.1.2 Design of Experiments (DoE) 
A process can be represented as a combination of operations which transform inputs 
(e.g. raw materials) in outputs (e.g. finished product). It may be influenced by 
controllable and measurable factors (e.g. temperature, concentration and pH), and 
non-controllable factors (e.g. impurities), both able to affect the characteristics of the 
experimental response. Thus, the knowledge of these factors permits to control the 
process and the final product characteristics. 
The Design of Experiments (DoE) considers the experiment as a system composed of 
independent variables (experimental factors) and dependent variables (experimental 
responses). DoE measures and analyzes the effects of the changes in the parameters 
affecting the system properties (experimental responses). 
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The term “experimental factor” identifies a parameter supposed to influence the 
tested phenomenon and whose variation causes a more or less intense variation of the 
experimental responses, i.e. data obtained experimentally (Phan-Tan-Luu & Cela, 
2009). 
The experimental factors can be qualitative or quantitative and the alternatives in 
which they occur are defined levels that identify the experimental domain, or the area 
of interest of the study. 
In the development of the DoE it is necessary to: 
1. recognize and state the contest; 
2. select the variables and their levels; 
3. choose the experimental responses; 
4. choose the experimental plan (DoE); 
5. perform the experiments; 
6. point out data statistical analysis. 
In order to obtain an equation expressing the influence of the experimental factors on 
the response, it is necessary to postulate a mathematical model suitable for the 
description of the studied phenomenon. The main model used for the study of many 
systems is a polynomial model of the first, second, or third degree (Phan-Tan-Luu & 
Cela, 2009). 
The number of the model coefficients increases with increasing the degree of the 
polynomial and, after the third degree, the number of experiments to be carried out 
becomes extremely high. However, a polynomial of second or third degree generally 
represents a phenomenon (Phan-Tan-Luu & Cela, 2009). 
Once chosen the mathematical model, it is necessary to define the experiments to be 
performed in order to calculate the model coefficients and to evaluate the effect of the 
variables on the experimental response.  
A set of experiments can be represented by means of the experimental matrices, or 
"tables" constituted by N lines, corresponding to N experiments, and k columns, 
corresponding to k variables studied. 
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The variables are the parameters that will potentially affect the characteristics of the 
system and they may be qualitative (e.g. the type of excipient) or quantitative (e.g. the 
pH value). In order to assess the interaction between the variables and the responses, 
variables must be made comparable to each other by transforming them into codified 
or normalized variables, according to the equation 4.1: 
 
   
     
 
   
       (4.1) 
 
where xi is the value of the normalized variable, Ui is the value of the natural 
variable, Ui
0
 is the value of the natural variable in the middle of the experimental 
domain, ΔUi is the range of the natural variable. 
Experimental matrices are constructed in terms of normalized values and their choice 
depends on the postulated model. The experimental plan, which describes the 
experiments to be performed, is obtained by transforming the normalized values in 
experimental values.  
Once performed the experiments and obtained the experimental responses, it is 
possible to calculate the coefficients of the postulated model (Phan-Tan-Luu & Cela, 
2009).  
Screening of independent variables 
A system can be influenced by a large number of variables. The screening technique 
allows to assess whether a particular variable can influence the system by analyzing 
the change that this variable induces to a certain parameter, assumed to characterize 
the system of interest (experimental response). 
In the screening technique it is assumed that a linear relationship between variables 
and responses exists, and the model employed will be a first degree polynomial. 
To obtain the experimental plan with the minimum number of experiments, the 
appropriate matrix to the experimental domain must be selected. 
Finally, the Analysis of Variance (ANOVA) was performed in order to evaluate 
whether the experimental response varies significantly in relation to the considered 
variables. With the study of screening the variables able to influence the system may 
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be identified since they determine a significant variation of the experimental 
responses. 
Variables resulting not significant for the system may be arbitrarily fixed since their 
variation, within the experimental domain, does not determine a change of the 
experimental responses (Cela, et al., 2009). 
Study of the effects of variables 
The DoE could be also used to study how some selected variables affect the 
experimental responses and the presence of interactions between them. 
In this case the mathematical model that is assumed to describe adequately the system 
is represented by a second degree polynomial at least. Furthermore, a matrix, able to 
give a good estimation of the coefficients, must be chosen, e.g. a full factorial matrix 
involving all combinations between variables. 
Also in this case ANOVA and the estimation of the coefficients significance must be 
carried out. 
Finally, the validity of the mathematical model is evaluated by calculating the 
multiple R-squared (R
2
) and Adjusted R-squared (R
2
A).  
Study of mixtures 
In many product development areas, the application of experiments involving 
mixtures or blends is quite common. Generally, in mixture studies the interest is in 
developing better or innovative formulations with optimum characteristics 
(responses) able to satisfy determined requirements (Voinovich, et al., 2009). 
In the case of mixtures, the variables are quantitative and continuous and they show 
two important properties: 
1. they are dependent being their sum equal to 1 or 100% of the mixture 
composition; 
2. they are dimensionless.  
Shape and size of the experimental domain depend on the number of formulation 
variables considered in the study. For k variables, a k-1 dimensions domain will be 
obtained. 
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When k=3 the experimental domain is represented by an equilateral triangle, whose 
vertices correspond to the pure components, the sides to the binary mixtures and the 
interior points to the ternary mixtures (figure 4.1). 
 
 
Figure 4.1. Representation of experimental domain for 3 factors mixtures without 
constraint. 
 
It is also possible to limit the experimental domain by introducing quantitative 
constraints and relational limits between variables. Once defined the experimental 
domain, a mathematical model, able to describe the system, must be postulated and a 
matrix suitable to calculate the model coefficients must be chosen. 
The ability of the model to describe the system and to predict the experimental 
response is assessed by calculating R
2
 and R
2
A coefficients and by performing some 
additional experiments (test points).  
The choice of the test points is fundamental in order to have correct information 
about the quality of the predictive capacity of the model (Cornell, 1990). These points 
should be placed where the variance of the measured value is higher. If at the test 
points the experimental values are very similar to those estimated by using the model, 
it can be concluded that the mathematical model is appropriate to describe the system 
and to predict the experimental responses. Otherwise, if the difference between 
experimental and calculated values is too high, this means that probably coefficients 
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have not been estimated with sufficient accuracy and that the model does not fit well 
the system. 
In this case a model of higher degree must be chosen to describe the complexity of 
the system and a higher number of experiments must be performed in order to have a 
more accurate measure of the coefficients. 
If the model provides a good fitting of data it will be possible to create the 
isoresponse surfaces describing the variation of the response as a function of the 
composition of the mixture (figure 4.2). The isoresponse surface could be used to 
choose the mixture having the desired response. 
For systems including several experimental responses, the overlap of the isoresponse 
surfaces, allows to identify an area of "optimum", which contains the mixture 
composition able to give the best experimental responses (Voinovich, et al., 2009). 
 
 
Figure 4.2. Examples of two-dimensional (left) and three-dimensional (right) 
isoresponse surfaces. 
 
4.2 Materials  
The following were used: sodium carboxymethylcellulose E466 medium viscosity, 
talc PHARMA USP Ph.Eur., magnesium stearate FU-Ph.Eur., microcrystalline 
cellulose T1 Ph.Eur., calcium phosphate tribasic E341, mannitol for direct 
compression, potassium phosphate monobasic, sodium hydroxide and sodium 
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chloride, all nine supplied by A.C.E.F. S.p.A. (Italy); Ludipress
®
 purchased from 
BASF The Chemical Company (Germany); mucin (from porcine stomach, type II), 
sodium butyrate 98%, acetonitrile and 5-aminosalicylic acid 95% (Mesalazine), all 
four supplied by Sigma-Aldrich (USA); hydroxypropylmethylcellulose (Metolose, 
hypromellose-USP, grade 90SH-100000SR, substitution type 2208, viscosity 100000 
mPa*s) purchased from Shin-Etsu Chemical Co., Ltd., (Japan); phosphoric acid and 
methanol HPLC Gradient Grade supplied by Acros Organics (Belgium) and J.T. 
Baker
®
 (Netherlands), respectively.  
In all preparations of solutions and buffers, deionized water was used. 
Characteristics, properties and applications of the new mucoadhesive polymers are 
described in detail in table 4.1. 
 
Table 4.1. Properties and applications of the new polymers used in the study.  
Polymers Properties Applications 
Sodium Carboxymethylcellulose 
(Sodium Carboxymethylcellulose 
E466 medium viscosity) 
Sodium salt of a polycarboxymethyl 
ether of cellulose. 
 
 
 
(Rowe, et al., 2006) 
 
 
 
Hydroxypropylmethylcellulose 
(Metolose, Hypromellose-USP) 
Partially O-methylated and O-(2-
hydroxypropylated) cellulose. 
 Hygroscopic polymer, 
practically insoluble in acetone, 
ethanol (95%), ether, and 
toluene; the aqueous solubility 
varies with the degree of 
substitution (DS). 
 Molecular weight ranges from 
90-700 kDa. 
 DS of 0.80; viscosity of a 2% 
aqueous solution of 470 mPa*s; 
the pH of a 1% aqueous solution 
is 7. 
 High concentrations, usually 3-
6%, of the medium-viscosity 
grade are used to produce gels. 
 
 
 Nonionic, hygroscopic polymer; 
soluble in cold water, forming a 
viscous colloidal solution; 
practically insoluble in 
chloroform, ethanol (95%), and 
ether, but soluble in mixtures of 
methanol and dichloromethane, 
and mixtures of water and 
alcohol. 
 It is widely used in oral and 
topical pharmaceutical 
formulations, mainly for its 
viscosity-increasing properties. 
 It may also be used as a tablet 
binder and disintegrant, and to 
stabilize emulsions. 
 Its mucoadhesive properties are 
used in various pharmaceutical 
formulations to localize and 
modify the release kinetics of 
active principles applied to 
mucous membranes. 
 Moreover it can be used to 
prevent post-surgical tissue 
adhesions, for bone repair and 
to realize dermatological 
patches. 
 
 It is widely used in oral, 
ophtalmic and topical 
pharmaceutical formulations. 
 In oral products, it is primarily 
used as a tablet binder, in film-
coating, and as a matrix for use 
in extended-release tablet 
formulations. 
 It is also used as an emulsifier, 
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(Rowe, et al., 2006) 
 
 A 1% [w/w] aqueous solution 
exhibits a pH of 6.8. 
 A 2% aqueous solution shows a 
viscosity of 100000 mPa*s at 
20°C. 
 Methoxy content: 23.4%; 
hydroxypropoxy content: 9.5%. 
 The molecular weight is 
approximately 10-1500 kDa. 
suspending agent, thickening 
agent and stabilizing agent in 
topical formulations.  
 Moreover, it is used in the 
manufacture of films, capsules, 
as an adhesive in plastic 
bandages, and as a wetting 
agent for hard contact lenses. 
 
 
4.2.1 5-aminosalicylic acid (Mesalazine) 
5-aminosalicylic acid or Mesalazine (ME) (figure 4.3) is a nonsteroidal anti-
inflammatory drug (NSAID), belonging to the broader category of amino salicylic 
acids, with a selective action on the intestinal mucosa. ME exhibits a solubility of 
0.965 mg/mL and 3.2 mg/mL in phosphate buffer pH 6.8, both measured at 20°C. It 
is used for the treatment of inflammatory diseases of the gastro-intestinal tract 
(Bondesen, et al., 1987). ME presents a topical anti-inflammatory action on the 
intestinal mucosa thanks to its very slow absorption. Its mechanism of action involves 
the inhibition of the production of chemical mediators of inflammation such as 
arachidonic acid metabolites (prostaglandins, thromboxanes and leukotrienes). 
 
 
 
Figure 4.3. Structural formula of Mesalazine. 
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4.3 Methods 
 
4.3.1 Determination of intrinsic viscosity and Viscosity Average Molecular 
Weight of polymers 
Viscosity average molecular weights of sodium carboxymethylcellulose and 
hydroxypropylmethylcellulose were measured using the method described in Section 
2.3.1, at 20°C for sodium carboxymethylcellulose and at 25°C for 
hydroxypropylmethylcellulose. 
The operative conditions, i.e. the solvent and   and   values used for the two 
polymers are reported in table 4.2.  
 
Table 4.2. Operating conditions used for each polymer. 
Polymer Solvent K (x10
3
) 
[dL*g
-1
] 
α [-] References 
Sodium 
carboxymethylcellulose 
NaOH 0.5 M 0.5370 0.730 
(Eremeeva & 
Bykova, 1998) 
Hydroxypropylmethylcellulose Water 0.3390 0.880 (Vázquez, et al., 
1996) 
 
4.3.2 Powder flowability measures 
Powder flowability (polymers in pure form and in mixture) was evaluated by means 
of the method described in Section 2.3.2.  
 
4.3.3 Preparation of mucoadhesive tablets 
Tablets were prepared by direct compression of the powders, using a single punch 
tablet press (COSALT type, Officina CO.STA. S.r.l., Italy) fitted with a flat-faced 
circular punch (5 mm diameter). The weight of the tablets ranges from 49 to 114 mg 
and the thickness ranges from 3 to 4 mm.  
 
4.3.4 Technological characterization of tablets  
The tests of uniformity of mass and tablet crushing strength were performed 
according to the methods described in Sections 3.3.4 and 2.3.4, respectively. 
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4.3.5 Evaluation of tablets behavior in aqueous medium 
The evaluation of tablets behavior in aqueous medium was performed by measuring 
the water uptake and the swelling of tablets with the method described in Section 
2.3.5 using phosphate buffer as medium. Moreover, the wettability of placebo tablets 
was measured according to the method described in Section 3.3.5 (Wettability and 
Contact Angle). 
 
4.3.6 Tensile Test for the detection of tablets mucoadhesive properties 
The assessment of the mucoadhesive properties of the tablets was performed 
according to the method indicates as procedure 3 and described in Section 3.3.6. 
 
4.3.7 Dissolution test 
Tablets containing sodium butyrate and mesalazine were subjected to dissolution test, 
performed according to FUI XII ed. (F.U.I., 2008), with a dissolution apparatus 2 
(Sotax AT7 Smart, Sotax, Switzerland) at 100 rpm. The dissolution tests were carried 
out at 37±0.5°C in 900 mL of simulated intestinal fluid (phosphate buffer pH 6.8) as 
dissolution medium. During the release studies, 1 mL of dissolution medium sample 
was removed and filtered; SB e ME quantifications were performed using the 
methods reported in Sections 3.3.8 and 4.3.8, respectively. The volume removed was 
replaced each time with fresh medium. Results are averaged from three replicated 
experiments.  
 
4.3.8 Analytical method for the determination of mesalazine 
The quantitative determination of mesalazine was realized by UV-Vis 
spectrophotometric analysis (UV-Vis spectrophotometer, Varian Cary 50 Scan, 
Agilent Technologies, USA) using a detection wavelength of 327 nm. In figure 4.4 is 
reported an example of the spectrum. 
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Figure 4.4. Example of the absorption spectrum of mesalazine in phosphate buffer pH 6.8. 
 
4.3.9 Planning of experiments and data analysis 
Experiments were planned using the software Nemrodw (NewrodW software version 
2000-D, D. Mathieu, J. Nony, R. Phan-Tan-Luu, , LPRAI Marseille France). 
 
4.4 Results and Discussion 
In order to develop sustained-release mucoadhesive tablets, 
hydroxypropylmethylcellulose (HPMC), a non-ionic polymer well-known for its 
extended-release properties, was tested (Rahman, et al., 2010). 
The properties of HPMC have been compared with those of the other polymers 
previously studied.  
In this phase of the study a different type of sodium carboxymethylcellulose was used 
because of the necessity to change the supplier. In particular, the new NaCMC, 
indicated as NaCMC-B, presents different degree of substitution and viscosity and 
consequently it needed to be characterized again.  
HPMC and NaCMC-B were subjected to the technological characterizations already 
planned for the other mucoadhesive polymers. 
Mixtures consisting in 60% [w/w] of polymer and 40% [w/w] of excipients blend 
(Ludipress
®
, microcrystalline cellulose T1, magnesium stearate and talc) were 
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prepared and subjected to flowability test. The results suggest that the powders have a 
discrete flowability and thus they provide a uniform filling of the compression 
chamber (table 4.3). 
 
Table 4.3. Results of the flowability test of the new polymers. 
Powder Hausner Index 
(HI) [-] 
Compressibility Index  
(CI) [-] 
Flowability 
HPMC-Excipients blend 1.25±0.04 19.83±2.80 Discrete 
NaCMC-B-Excipients blend 1.24±0.02 19.41±1.56 Discrete 
 
Therefore, it was possible to realize tablets with a good crushing strength value which 
ensures their resistance (94.75±12.85 N for HPMC and 63.57±4.28 for NaCMC-B). 
Afterward the abilities of hydration and swelling of the new polymers in phosphate 
buffer pH 6.8 were evaluated in terms of water uptake (WU) and swelling index (SI). 
The results have been compared with those previously obtained with the other 
polymers (figure 4.5). 
Graphs show that tablets containing polymers with ionic character (SA, NaCMC, 
NaCMC-B and XG) swell and absorb water in larger amounts than those containing 
non-ionic polymers (HEC and HPMC). The lower SI of tablets containing TG is 
presumably due to the chemical characteristics of the polymer. Indeed it is 
characterized by a very complex structure and by the presence of fractions having 
different solubility. 
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Figure 4.5. Water uptake [%] and swelling index [%] profiles of the tablets in phosphate 
buffer pH 6.8: comparison between different polymers. 
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The wettability of the new tablets was evaluated by measuring the contact angle 
between water and tablets.  
Figure 4.6 shows the contact angle values of the first 3.5 seconds after the deposition 
of the drop of water on tablets containing the various polymers.  
 
 
Figure 4.6. Tablets contact angles (CA [deg]). The horizontal line divides the values of angle 
less than 90°, expression of good wettability, from the values of angle between 90° and 180°, 
expression of poor wettability. 
 
Considering the average contact angles corresponding to 0.3 seconds after drop 
deposition (red dotted box), the non-ionic polymers (HEC and HPMC) show values 
of contact angle higher than 90°, unlike the other polymers. These results match the 
water uptake and swelling index data. Therefore, the assessment of tablets wettability 
may represent a complementary method for the evaluation of the polymer behavior in 
aqueous medium. 
The molecular weights of the two new polymers were determined by viscosimetric 
method and they resulted 117 kDa for NaCMC-B, and 96 kDa for HPMC. 
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Then mucoadhesive properties of tablets containing NaCMC-B and HPMC were 
measured in terms of maximum detachment force (Fmax) and work of adhesion (Wad) 
using the procedure 3 (table 3.5, Section 3.3.6). Figure 4.7 shows the values of Fmax 
and Wad of all seven kinds of tablets. 
 
 
 
Figure 4.7. Fmax [mN] (top) and Wad [mN*mm] (bottom) values of the tablets. The tensile 
test is performed using procedure 3.  
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NaCMC-B). In addition, HPMC presented high Fmax but the Wad value was lower 
than expected.  
The Texture analyzer used for the tensile strength measurements produces very 
narrow peaks, which can make the measurement of the area under the curve 
unreliable. This could explain the lack of consistency between the Wad and Fmax 
results (Ivarsson & Wahlgren, 2012). Thus only the Fmax measurements are included 
in the following discussion. 
The mucoadhesive properties of the tablets do not match the WU and SI data because 
the phenomenon of mucoadhesion is complex and influenced by numerous 
parameters. Hence, probably the hydration and swelling of the polymer are not the 
key factors in determining the mucoadhesion.  
Comparing the molecular weights of polymers with their mucoadhesive properties 
(Fmax) it is possible to confirm the trend previously observed: the lower the molecular 
weight the higher the mucoadhesive properties (figure 4.8). In particular the best 
mucoadhesive properties are obtained with polymers having a molecular weight 
around 100 kDa.  
 
 
Figure 4.8. Relationship between polymers molecular weight (  [   ]) and the 
mucoadhesive properties (Fmax [mN]) of the tablets in phosphate buffer pH 6.8 (procedure 3). 
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To carry out the study, two polymers with different ionic character, NaCMC-B and 
HPMC, were selected. The choice was determined according to the results concerning 
the mucoadhesive properties (NaCMC-B), and with the aim to obtain a sustained-
release formulation (HPMC). 
In order to assess if variables of formulation and the type of production process 
(direct compression or granulation-compression) influence the mucoadhesive 
properties and the release rate of the drug (experimental responses), the Design of 
Experiments techniques were employed.  
The formulation variables considered in the study are the following:  
 type of polymer (NaCMC-B or HPMC); 
 type of API (sodium butyrate, SB or mesalazine, ME); 
 type of diluent (calcium phosphate, CP or mannitol, MA). 
The variables (xi) selected for the study and their levels are reported in table 4.4.  
 
Table 4.4. Qualitative independent variables considered in the study of screening. 
VARIABLE DESCRIPTION ASSUMED LEVELS  
NORMALIZED 
LEVELS 
X1 TYPE OF API 
SB -1 
ME +1 
X2 TYPE OF POLYMER 
NaCMC-B -1 
HPMC +1 
X3 
TYPE OF 
EXCIPIENT 
MA -1 
CP +1 
X4 
TYPE OF 
PRODUCTION 
PROCESS 
DIRECT COMPRESSION -1 
GRANULATION-
COMPRESSION 
+1 
 
In order to evaluate if the selected variables were able to influence the two 
experimental responses, a DoE for the screening of the independent variables was 
used. The two selected experimental responses were: the maximum detachment force 
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(Fmax – Y1) to describe the mucoadhesive properties of the tablet and the time 
necessary to obtain the release of 50% of the drug (T50 – Y2) to describe drug release 
kinetics.  
During the screening, quantitative composition of the tablets were maintained 
constant. All the formulations contain: active ingredient 20% [w/w], polymer 45% 
[w/w], excipient 33% [w/w]. The formulation was completed with a mixture of talc 
and magnesium stearate (1:1) 2% [w/w], as lubricant for the compression process. 
Figure 4.9 shows the graphical representation of the screening. 
 
 
Figure 4.9. Graphical representation of the variables selected for the screening. 
 
 
The mathematical model postulated for the screening of the four experimental 
variables is:  
 
                                        (4.2) 
 
The experiments necessary to estimate the coefficients (bi) of the mathematical model 
were designed by employing a Hadamard matrix. 
The Hadamard matrix for four variables at 2 levels is reported in table 4.5. 
 
 
 
Type of API 
Type of polymer 
Type of excipient 
Type of process 
Drug release (T
50
) 
Mucoadhesive 
properties (Fmax) 
MUCOADHESIVE 
TABLETS 
QUALITATIVE 
INDEPENDENT 
VARIABLES  
(Xi) 
DEPENDENT 
VARIABLES 
(experimental 
responses Yi) 
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Table 4.5. Hadamard matrix for the analysis of 4 variables at 2 levels. 
 
N°Exp. X1 X2 X3 X4 
1  1  1  1 -1 
2 -1  1  1  1 
3 -1 -1  1  1 
4  1 -1 -1  1 
5 -1  1 -1 -1 
6  1 -1  1 -1 
7  1  1 -1  1 
8 -1 -1 -1 -1 
 
The matrix expressed in terms of normalized levels is then converted in the 
experimental plan (table 4.6) that describes the experiments required to estimate the 
mathematical coefficients.  
 
Table 4.6. Experimental plan for the screening. 
 
N°Exp TYPE 
OF API 
TYPE OF 
POLYMER 
TYPE OF 
EXCIPIENT 
TYPE OF PRODUCTION 
PROCESS 
1 ME NaCMC-B CP DIRECT COMPRESSION 
2 ME HPMC CP DIRECT COMPRESSION 
3 SB NaCMC-B MA DIRECT COMPRESSION 
4 SB HPMC MA DIRECT COMPRESSION 
5 SB NaCMC-B CP GRANULATION-COMPRESSION 
6 SB HPMC CP GRANULATION-COMPRESSION 
7 ME NaCMC-B MA GRANULATION-COMPRESSION 
8 ME HPMC MA GRANULATION-COMPRESSION 
 
All the experiments were performed and some repetitions were carried out in order to 
estimate the variance. 
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Tablets were characterized by mucoadhesive test (procedure 3) and dissolution test 
and the results are reported in table 4.7.  
The experimental responses were used to estimate the coefficient of the mathematical 
model, instead the ANOVA was performed in order to validate the analysis.  
 
Table 4.7. Experimental responses obtained for each experiment. 
N°Ex
p 
X1 X2 X3 X4 Y1 Y2 
TYPE 
OF API 
TYPE OF 
POLYMER 
TYPE OF 
EXCIPIEN
T 
TYPE OF 
PRODUCTION 
PROCESS 
Fmax 
[mN] 
T50 
[min] 
1 ME NaCMC-B CP DIRECT 
COMPRESSION 
422±55 65±1 
2 ME HPMC CP DIRECT 
COMPRESSION 
450±50 300±2 
3 SB NaCMC-B MA DIRECT 
COMPRESSION 
254±9 45±1 
4 SB HPMC MA DIRECT 
COMPRESSION 
215±57 45±1 
5 SB NaCMC-B CP GRANULATION
-COMPRESSION 
304±53 45±1 
5* SB NaCMC-B CP GRANULATION
-COMPRESSION 
300±50 40±2 
6 SB HPMC CP GRANULATION
-COMPRESSION 
360±52 30±1 
7 ME NaCMC-B MA GRANULATION
-COMPRESSION 
423±23 50±2 
8 ME HPMC MA GRANULATION
-COMPRESSION 
444±44 210±3 
* the test was repeated for the calculation of the standard deviation 
 
The analysis revealed that the variables able to influence the maximum detachment 
force (Y1) are the type of active ingredient and the type of excipient (figure 4.10). 
This means that the mucoadhesive properties vary significantly depending on the 
delivered drug and the type of the excipient.  
On the other hand, variables able to significantly influence the drug release (Y2) are 
the type of active ingredient and the type of polymer (figure 4.10). 
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Results show that the type of production process has no influence on both the 
experimental responses; for this reason, this variable has been fixed and all tablets 
were then produced by direct compression. 
 
 
Figure 4.10. Graphical representation of the significance of the estimated coefficients for the 
responses Y1 (left) and Y2 (right). The asterisk (*) marks the significant variables. 
 
In order to assess the type of the effect exerted by the formulation variables on the 
experimental responses, a DoE for the study of the effects of qualitative variables was 
used (table 4.8).  
 
Table 4.8. Variables for the study of effects. 
 
VARIABLES DESCRIPTION 
ASSUMED 
LEVELS  
NORMALIZED 
LEVELS 
X1 TYPE OF API 
SB -1 
ME +1 
X2 TYPE OF POLYMER 
NaCMC-B -1 
HPMC +1 
X3 TYPE OF EXCIPIENT 
MA -1 
CP +1 
 
For this purpose, a second degree polynomial model was postulated: 
* 
* 
* 
* 
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                                                       (4.3) 
 
This model takes into account not only the effect of the single experimental variables 
but the presence of the interactions, too. 
The experiments necessary to estimate the 7 coefficients of the mathematical model 
are designed using a full factorial matrix (2
3
//8), which considers all the possible 
combinations between the variables and corresponds to the experimental plan shown 
in table 4.9. 
 
Table 4.9. Experimental plan for the study of the effect of variables. 
 
N°Exp. X1 X2 X3 
TYPE OF API TYPE OF 
POLYMER 
TYPE OF EXCIPIENT 
1 SB NaCMC-B MA 
2 ME NaCMC-B MA 
3 SB HPMC MA 
4 ME HPMC MA 
5 SB NaCMC-B CP 
6 ME NaCMC-B CP 
7 SB HPMC CP 
8 ME HPMC CP 
 
The composition of the tablets was maintained constant during the study. All the 
formulations contain: active ingredient 20% [w/w], polymer 45% [w/w], excipient 
33% [w/w], and a mixture of talc and magnesium stearate (1:1) 2% [w/w]. All the 
experiments were performed and the experimental responses (Fmax - Y1 and T50 - Y2) 
were evaluated. Results are reported in table 4.10. 
The experimental responses were used to estimate the coefficient of the mathematical 
model, while the ANOVA was performed in order to validate the analysis.  
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Table 4.10. Experimental responses obtained from each experiment. 
N°Exp. X1 X2 X3 Y1 Y2 
TYPE OF 
API 
TYPE OF 
POLYMER 
TYPE OF 
EXCIPIENT 
Fmax 
[mN] 
T50 
[min] 
1 SB NaCMC-B MA 254±10 45±2 
2 ME NaCMC-B MA 415±23 40±5 
3 SB HPMC MA 215±42 45±1 
4 ME HPMC MA 420±27 240±10 
5 SB NaCMC-B CP 255±25 25±1 
5* SB NaCMC-B CP 220±34 20±3 
6 ME NaCMC-B CP 422±56 65±2 
7 SB HPMC CP 372±25 25±1 
8 ME HPMC CP 450±52 300±5 
* the test was repeated for the calculation of the standard deviation 
 
Data highlighted that Y1 or maximum detachment force is influenced by the type of 
the drug, while the kinetics of release (Y2) is influenced by the type of drug, type of 
polymer, and by the interactions API-polymer and API-excipient (figure 4.11). 
 
 
 
 
Figure 4.11. Graphical representation of the significance of the estimated coefficients for the 
responses Y1 (left) and Y2 (right). The asterisk (*) marks the significant variables. 
 
* 
* 
* 
* 
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The graphical analysis of the effects shows that, for the same polymer used, the 
replacement of sodium butyrate with mesalazine leads to an increase in the maximum 
detachment force (figure 4.12). 
 
 
Figure 4.12. Graphical representation of the influence of the type of API on the 
mucoadhesive properties. 
 
Figure 4.13 shows the graphical representation of the effect of the type of active 
ingredient and the type of polymer on T50 values.  
 
Figure 4.13. Graphical representation of the effect of the type of API and the type of polymer 
on T50 values. 
 
In presence of sodium butyrate, drug release rate is always fast, due to its high 
solubility, instead for mesalazine, a poor water soluble drug, the release rate is 
markedly affected by the type of polymer.  
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In this case the slower release rate is obtained in presence of HPMC probably due to 
the creation of a more viscous gel layer. The co-presence of a water insoluble 
excipient can lead to a further slowdown in drug release rate. 
Results highlight that (figure 4.14): 
 the replacement of sodium butyrate with mesalazine leads to an increase in the 
mucoadhesive properties and in the time required to obtain the drug release; 
 the replacement of NaCMC-B with HPMC leads to a significant increase in 
the T50 in the case of mesalazine; 
 the API-polymer and API-excipient interactions are relevant in determining 
the drug release rate. In particular, the poorer the water solubility of the API 
and the excipient, the slower the drug release.  
Consequently, the formulations that allow obtaining the better mucoadhesive 
properties and the slower dissolution rate of the drug are those containing HPMC as 
polymer and CP as diluent.  
 
 
 
Figure 4.14. Effects of variables and their interactions on the two experimental responses. 
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Finally, a study of mixtures was performed using DoE technique in order to evaluate 
the influence of the amount of the three formulation variables (SB or ME, CP and 
HPMC) on the two experimental responses. For this purpose each API was studied 
separately. To carry out this study the quantitative limits for the components of the 
mixture were initially fixed (table 4.11), because the final dosage form must contain 
at least 20% [w/w] of drug and must present a good mucoadhesiveness and slow 
release. 
 
Table 4.11. Variables and quantitative limits selected for the study of mixtures. 
VARIABLE CODE LOWER LIMIT [%] HIGHER LIMIT [%] 
Amount of API X1 20 100 
Amount of HPMC X2 10 60 
Amount of CP X3 0 100 
Mixture of talc and magnesium stearate fixed 2% 
 
The quantitative limits of the three variables define the experimental domain shown 
in figure 4.15. 
 
Figure 4.15. Experimental domain for the study of mixtures. 
 
The mathematical model selected to describe the relationship between variables and 
experimental responses is a polynomial equation of the second degree: 
CP (100%) 
API (100%) 
HPMC 
(100%) 
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                                                     (4.4) 
 
A matrix consisting of 13 experiments is used to estimate the coefficients. In order to 
reduce the number of the experiments the exchange algorithm was used. The 
experiments were selected on the basis of three criteria: D-criterion (Det(M)**1/p), 
the A-criterion o trace criterion (Trace(X’X)-1) and variance function (dMax). The 
best combination of these three criteria is called optimal and the corresponding design 
matrix is called optimal design matrix (Cornell, 1990; de Aguiar, et al., 1995). 
The optimal design matrix is that having the maximum Det(M)**1/p value, the 
minimum Trace(X’X)-1 value and the dMax close to 1.  
The values of the three criteria are reported in figure 4.16. 
 
 
 
 
 
Figure 4.16. Values of the three criteria considered in the choice of the optimal design 
matrix. 
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On the basis of Det(M)**1/p value, Trace(X’X)-1 and the dMax values the matrix 
consisting of 7 experiments was selected.  
The experiments are resumed in table 4.12. 
 
Table 4.12. Experimental plan consisting of 7 experiments selected to carry on the study of 
mixtures.  
N°Exp. 
X1 X2 X3 
API 
[%] 
HPMC 
[%] 
CP 
[%] 
1 88 10 0 
2 38 60 0 
3 20 10 68 
4 20 60 18 
5 63 35 0 
6 54 10 34 
7 20 35 43 
 
The experimental plan was realized for both type of API. All the experiments were 
performed and tablets were subjected to mucoadhesion and dissolution tests.  
Results obtained are discussed in the following sections.  
 
 Tablets containing SB 
Results of tablets containing sodium butyrate are reported in table 4.13. 
ANOVA was used to verify the capability of the model to describe the phenomenon 
and thus its predictive ability.  
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Table 4.13. Experimental responses obtained for tablets containing SB. 
N°Exp. 
X1 X2 X3 Y1 Y2 
SB 
[%] 
HPMC 
[%] 
CP 
[%] 
Fmax 
[mN] 
T50 
[min] 
1 88 10 0 556±48 7±0 
2 38 60 0 319±27 35±2 
3 20 10 68 204±33 20±1 
4 20 60 18 355±33 45±3 
5 63 35 0 306±46 30±2 
5* 63 35 0 320±37 35±2 
6 54 10 34 373±40 7±1 
7 20 35 43 306±55 32±2 
* the test was repeated for the calculation of the standard deviation 
 
For an easier analysis of the response behavior over the whole experimental domain 
in function of the three quantitative variables, the isoresponse surfaces were drawn 
using the software NemrodW (NewrodW software version 2000-D, D. Mathieu, J. 
Nony, R. Phan-Tan-Luu, , LPRAI Marseille France) (figures 4.17 and 4.18). 
 
 
Figure 4.17. Isoresponse surfaces regarding Y1 (Fmax), obtained for tablets containing SB 
(green symbols represent the initial experiments, pink symbols represent the test points).  
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Figure 4.18. Isoresponse surfaces regarding Y2 (T50), obtained for tablets containing SB 
(green symbols represent the initial experiments, pink symbols represent the test points).  
 
Each line of the isoresponse surface represents a specific value of Fmax or T50.  
The obtained surfaces have a curvilinear shape that indicates the presence of a 
complex system where all variables can influence the responses. 
To test if the postulated model is predictive, some additional tests called test points 
(T000N) have been performed. Experimental values of Fmax and T50 were compared 
with the values calculated by using the estimated coefficients (table 4.14). The 
smaller the difference between experimental values and calculated values, the better 
the predictive ability of the model. 
The analysis of the test points demonstrates that the model has a good predictive 
capacity. 
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Table 4.14. Experimental responses of the test points for SB. 
 
TEST 
POINTS 
EXPERIMENTAL 
VALUES 
CALCULATED 
VALUES 
DIFFERENCE BETWEEN 
EXPERIMENTAL AND 
CALCULATED VALUES 
Y1 
[mN] 
Y2 
[min] 
Y1 
[mN] 
Y2 
[min] 
Y1 
[mN] 
Y2 
[min] 
SB 
T0001 370 ±62 25 ±1 379 21 9 4 
T0002 319 ±40 40 ±3 306 37 13 3 
T0003 292 ±35 30 ±2 284 26 8 4 
T0004 321 ±48 35 ±2 320 38 1 3 
 
The overlap of the two isoresponse surfaces, obtained for both the experimental 
responses, allows to identify an area (a combination of the three variables) of the 
experimental domain, called “optimum” corresponding to formulations with good 
mucoadhesion, extended-release and high amount of drug (figure 4.19).  
 
Figure 4.19. Overlapping of the two isoresponse surfaces for the tablets containing SB: the 
red circle identifies the optimum (green numbers are the Fmax values and black numbers are 
the T50 values). 
HPMC CP 
SB 
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In the case of SB that area corresponds to a T50 value of about 30 minutes, a Fmax 
value of about 320 mN and an amount of sodium butyrate of about 55% [w/w]. 
 
 Tablets containing mesalazine 
Results of tablets containing mesalazine are reported in table 4.15. 
ANOVA was used to verify the capability of the model to describe the phenomenon 
and thus its predictive ability. 
Results show that the second-degree polynomial model is suitable to describe the 
system for the two experimental responses. 
 
Table 4.15. Experimental responses obtained for tablets containing mesalazine. 
N°Exp. 
X1 X2 X3 Y1 Y2 
ME 
[%] 
HPMC 
[%] 
CP 
[%] 
Fmax 
[mN] 
T50 
[min] 
1 88 10 0 433±53 8±2 
2 38 60 0 466±55 360±3 
3 20 10 68 342±53 45±5 
4 20 60 18 421±71 300±4 
5 63 35 0 430±58 450±8 
5* 63 35 0 427±48 420±1 
6 54 10 34 417±45 7±2 
7 20 35 43 405±62 270±5 
* the test was repeated for the calculation of the standard deviation 
 
For an easier analysis of the response behavior over the whole experimental domain 
in function of the three quantitative variables, the isoresponse surfaces were drawn 
using the software NemrodW (figures 4.20 and 4.21). 
The obtained surfaces have a curvilinear shape that indicates the presence of a 
complex system where all variables can influence the responses. 
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Figure 4.20. Isoresponse surfaces regarding Y1 (Fmax), obtained for tablets containing ME 
(green symbols represent the initial experiments, pink symbols represent the test points). 
 
 
Figure 4.21. Isoresponse surfaces regarding Y2 (release rate of API), obtained for tablets 
containing ME (green symbols represent the initial experiments, pink symbols represent the 
test points). 
 
Even for tablets containing ME, four test points (T000N) have been performed to 
verify the predictive ability of the model. Experimental values of Fmax and T50 were 
compared with the values calculated by using the estimated coefficients (table 4.16).  
The analysis of the test points demonstrates that the model has a good predictive 
capacity. 
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Table 4.16. Experimental responses of the test points for ME.  
 
TEST 
POINTS 
EXPERIMENTA
L VALUES 
CALCULATED 
VALUES 
DIFFERENCE BETWEEN 
EXPERIMENTAL AND 
CALCULATED VALUES 
Y1 
[mN] 
Y2 
[min] 
Y1 
[mN] 
Y2 
[min] 
Y1 
[mN] 
Y2 
[min] 
ME 
T0001 434±59 320±5 451 287 17 33 
T0002 454±22 42±7 471 429 17 9 
T0003 410±13 300±2 421 280 11 20 
T0004 488±33 380±3 470 388 18 8 
 
The overlap of the two isoresponse surfaces, obtained for both the experimental 
responses, allows to identify an area of optimum within the experimental domain, 
corresponding to formulations with good mucoadhesion, extended-release and high 
amount of drug (figure 4.22).  
 
 
Figure 4.22. Overlapping of the two isoresponse surfaces for the tablets containing ME: the 
red circle identifies the optimum (green numbers are the Fmax values and black numbers are 
the T50 values).  
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In the case of ME that area corresponds to a T50 value of about 90 minutes, a Fmax 
value of about 420 mN and an amount of mesalazine higher than 50% [w/w]. 
For tablets containing ME, areas with higher values of T50 could be selected. 
However, the preferred value of T50 is about 90 minutes, since mucin turnover ranges 
from 4 to 6 hours in the intestine. 
 
Since polymers used to develop mucoadhesive tablets are able to form a swellable 
matrix and produce a sustained-release dosage form, some consideration about the 
drug release can be made. 
 
 Drug release from hydrophilic swellable matrices 
Swelling-controlled systems, also known as hydrogel matrices, polymeric matrices, 
hydrocolloid matrices or hydrophilic matrices, can be utilized to modify the drug 
release rate. Among the different types of swelling-controlled systems, the free-
swellable matrices, in which the matrix can swell unhindered, are the most common.  
When a swellable matrix is immersed in water, water molecules interact with the 
hydrophilic groups of the polymer. As the water is further soaked into the matrix, the 
spaces inside the polymer network are filled and hence the drug particles are 
dissolved. Water acts as a plasticizer and reduces the polymer glass transition 
temperature, Tg, until it reaches the temperature of the system; as a consequence, the 
polymer chains relax, become more flexible and the polymer swells. For example, in 
the case of HPMC, the glass transition temperature decreases from 184°C to 37°C 
when the dry form of the polymer is immersed in water (Lofthus, 2005). 
The swelling causes great changes in the matrix with regard to the structural organization of 
the polymer and the mobility of its chains, affecting in this way the drug release.  
The most important key factors determining the drug release from a hydrophilic matrix are 
the following: 
 polymer content  
 drug:polymer ratio  
 drug solubility 
 viscosity of polymer 
126 
 
 
 
 solubility of excipients  
 structure and hydrophilicity of polymer (Lofthus, 2005). 
When a swelling matrix is immersed in water it is possible to identify two or three 
different fronts (see figure 4.23). 
Erosion front: is the interface between the outermost edge of the matrix and the 
water; at this interface the polymer can reach a level of hydration that allows it to 
disentangle and dissolve, and hence, to erode. 
Swelling front: is the front where the polymer swells; the swelling and dissolution 
properties of the polymer are important in determining the matrix dimensions and the 
diffusion pathways that the drug may take to leave the system. This front always 
moves inwards towards the core of the system. 
Diffusion front: is present only if the delivered drug has a low solubility or a slow 
dissolution rate. It is located between the swelling and the erosion fronts. The 
diffusion front in the rubbery phase of the matrix represents the boundary where the 
drug becomes dissolved. As the swelling front does, also the diffusion front moves 
inwards towards the center of the matrix. The diffusion front is present only if the 
drug dissolves after the polymer has swelled. Since the polymer swells, the drug 
diffusivity increases as a consequence of the increased water content. When the water 
concentration exceeds the solubility of the drug, complete dissolution occurs. The 
drug can then diffuse out of the matrix. As the swelling of the matrix advances 
inwards towards the center, the diffusional pathway of the drug increases, and so the 
release rate of the drug will gradually diminish (Lofthus, 2005; Siepmann & 
Siepmann, 2008). 
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Figure 4.23. Representation of the three fronts present in a swelling-controlled drug 
delivery (Siepmann & Siepmann, 2008). 
 
After the polymer swelled, the drug can be released from the matrix by diffusional 
mechanisms, (Fickian mechanism) or other mechanisms, such as erosion or 
convective release. The release of the drug is controlled by the interaction between 
the solvent, the polymer and the drug, and the kinetics depends on the development of 
drug gradient in the gel layer. Therefore the thickness of the gel, the drug loading and 
solubility are the major factors that determine the drug release kinetics. For a non-
swellable polymer the drug release is almost solely dependent on diffusion. 
Time-independent, non-Fickian or case II transport of the drug can be observed in a 
two-dimensional film of hydrophilic polymer when polymer dissolution is equal to 
the polymer swelling. More common, in hydrophilic matrices is the occurrence of a 
transport mechanism intermediate between Fickian and non-Fickian, namely 
anomalous transport where the polymer relaxation and erosion of the polymer chains 
contribute to non-Fickian drug release (Lofthus, 2005; Fu & Kao, 2010). 
Models for the description of release mechanisms 
Many different mathematical models have been proposed to describe the drug release 
mechanisms from hydrophilic matrices. The use of an appropriate equation may 
allow to calculate and to predict these processes. However, at the present the most 
common equations have limitations to their use, as it is necessary to make certain 
assumptions about the models. 
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The Ritger-Peppas equation  
The Ritger-Peppas equation is a semi-empirical model for the analysis of release data.  
 
  
  
                        (4.5) 
 
Where Mt is the amount of drug released at time t, M∞ is the amount of solute 
released after infinite time, Mt/M∞ is the fractional solute release, t is the release time, 
k is a constant incorporating structural and geometrical characteristics of the system, 
and n is the release exponent which might be indicative of the mechanism of drug 
release (Lofthus, 2005; Siepmann & Siepmann, 2008). 
This equation is used to study the mechanism of release, because it has favorable 
aspects as regards limitations and assumptions. One assumption that must be made is 
that there are perfect sink conditions during the swelling, and that diffusion is 
concentration independent. The Ritger-Peppas equation can only be applied to the 
first 60% of fractional drug release (Lofthus, 2005).  
The release of drug from the matrices depends mainly on diffusion through the 
matrix, swelling of the polymer and erosion of the swollen polymer. Diffusional 
release shows first order kinetics or Fickian kinetics. In the case of Fickian 
mechanism the rate of drug diffusion is much less than that of polymer relaxation. 
Thus the release will be determined chiefly by the drug diffusion in such a system (Fu 
& Kao, 2010). In the case of Fickian release the release kinetics are therefore 
proportional to the square root of time. With a pure diffusional drug release, the 
diffusional coefficient n is equal to 0.50 if the swellable device is a thin film or 0.45 
and 0.43 if the system has a cylindrical or spherical shape, respectively (see table 
4.17).  
For Case II system, the reverse is true. The rate of drug diffusion is much larger than 
that of polymer relaxation. A characteristic of Case II mechanism is that the rate of 
interface movement is constant, so that the released amount is directly proportional to 
time. In the anomalous case, the rates of drug diffusion and polymer relaxation are 
about the same size (Fu & Kao, 2010). 
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Table 4.17. Values of the diffusional exponent n and mechanism of diffusional release for 
controlled-release systems. 
 
Diffusional exponent Drug release 
mechanism Thin film Cylindrical shape Spherical shape 
0.50 0.45 0.43 Fickian diffusion 
0.50<n<1.00 0.45<n<1.00 0.43<n<1.00 Anomalous 
1.00 1.00 1.00 Zero-order release 
 
In order to describe the drug release mechanisms from hydrophilic matrices 
constituted by HPMC, the dissolution profiles reported in figures 4.24 and 4.25 were 
fitted using the exponential equation proposed by Ritger and Peppas. 
 
 
Figure 4.24. Dissolution profiles of all the formulations containing SB. 
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Figure 4.25. Dissolution profiles of all the formulations containing ME. 
 
The fitting has permitted to evaluate the value of the exponent n for all the different 
formulations and thus to determine the drug release mechanism. Results are reported 
in table 4.18. 
Results show that, with both types of drugs, the dissolution profiles of the 
formulations number 1 and 6 are very fast and it is not possible to use the equation 
proposed by Ritger and Peppas. In the other cases the release exponent assumed a 
value ranging from 0.480 to 0.813 and thus the release mechanism is anomalous. This 
means that the drug release is a function of both dissolution and diffusion 
mechanisms. However, when the n value is closed to 0.45 the drug release is mainly 
due to the diffusion.  
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Table 4.18. Fitting parameters of the Ritger and Peppas exponential equation calculated for 
all the dissolution profiles. 
Formulation Fitting parameters 
N°  SB 
[%] 
HPMC 
[%] 
CP 
[%] 
n 
[-] 
K 
[-] 
R2 
[-] 
1 88 10 0 - - - 
2 38 60 0 0.544 66.698 0.998 
3 20 10 68 0.655 112.665 0.999 
4 20 60 18 0.606 61.142 0.999 
5 63 35 0 0.813 90.456 0.996 
6 54 10 34 - - - 
7 20 35 43 0.694 74.538 0.994 
 
Formulation Fitting parameters 
N°  ME 
[%] 
HPMC 
[%] 
CP 
[%] 
n 
[-] 
K 
[-] 
R2 
[-] 
1 88 10 0 - - - 
2 38 60 0 0.801 11.199 0.997 
3 20 10 68 0.480 49.646 0.999 
4 20 60 18 0.734 15.518 0.999 
5 63 35 0 0.764 10.690 0.997 
6 54 10 34 - - - 
7 20 35 43 0.773 15.648 0.999 
 
k is a constant incorporating structural and geometrical characteristics of the system 
and thus its value is a function of numerous variables such as form and dimension of 
the system, type of polymer, type of diluent, and nature of the active. In this case the 
geometrical characteristics of the matrices are similar and, as a consequence, its value 
is mainly affected by the formulation variables. Comparing the k values of the 
different formulations, it is possible to note that the higher the amount of polymer, the 
lower the k values and the higher the consistency of the gel layer (figure 4.26).  
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Figure 4.26. Relationship between the amount of polymer and k value. 
 
From figure 4.26 it is also possible to note that formulations containing ME present 
lower k values than those with SB and this is in agreement with the fact that ME, 
having a poor water solubility, concurs to produce a more compact and dense gelled 
matrix. These observations are consistent with the fact that the systems containing 
ME present the lower drug release rate.  
 
4.5 Conclusions 
The purpose of this Chapter was to develop sustained-release mucoadhesive tablets 
containing two drugs characterized by different water solubility (sodium butyrate and 
mesalazine), and having the intestinal mucosa as target. 
With this aim the range of polymers was further expanded by including HPMC. 
On the basis of mucoadhesion measurements and literature data, HPMC and NaCMC 
(type B) were selected to carry on this study.  
The DoE techniques were first used to evaluate the effects of the type of production 
process and the types of polymer, excipient and drug on mucoadhesion and drug 
release rate. Results revealed that mucoadhesion and the drug release rate are not 
affected by the type of the production process; however, the mucoadhesive properties 
depend on the type of excipient and active ingredient. On the other hand, variables 
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able to significantly influence the drug release are the type of active ingredient and 
the type of polymer. 
Particularly, the best results were obtained with HPMC and calcium phosphate. 
In order to develop a sustained-release dosage form for both the selected drugs, the 
DoE techniques were used again. 
The DoE was used to identify mixtures, containing drug, HPMC and calcium 
phosphate, and characterized by good mucoadhesion, extended-release of the active 
ingredient and high amount of drug. 
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 Chapter 5 
Conclusions 
 
 
The screening of polymers showing different physicochemical and mucoadhesive 
properties allowed to identify the parameter mainly influencing mucoadhesion. 
A good hydration of the polymer is fundamental for the activation of the 
mucoadhesion process. However, lower values of water uptake and swelling of the 
dosage form do not always correspond to lower values of mucoadhesive properties, as 
in the case of HPMC.  
Polymer molecular weight exhibits a good linear relation to mucoadhesion: the lower 
the polymer molecular weight, the higher the mucoadhesive properties of the dosage 
form. Hence, results suggest that polymer molecular weight is the most critical factor 
affecting mucoadhesion.  
To confirm these remarks, three standards of sodium carboxymethylcellulose with 
different molecular weight (90 – 250 – 700 kDa) were purchased from Sigma-Aldrich 
(USA). The three standards were characterized by the determination of the Viscosity 
Average Molecular Weight. Results are reported in table 5.1. 
 
Table 5.1. Molecular Weight and Viscosity Average Molecular Weight of the three standards 
of NaCMC. 
 
Polymer 
Molecular Weight 
[kDa] 
Viscosity Average 
Molecular Weight 
[kDa] 
NaCMC-90 90 42 
NaCMC-250 250 170 
NaCMC-700 700 607 
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Standard polymers were then used to prepare tablets containing 60% [w/w] of 
polymer and 40% [w/w] of excipients blend. However, due to the high cohesiveness 
and poor flowability and compressibility of the mixture containing NaCMC-700, this 
type of tablets was not produced.  
Nevertheless, tablets containing the other two standards were prepared and their 
mucoadhesive properties were evaluated using the procedure 3 (table 3.5, Section 
3.3.6) of the tensile test.  
In figure 5.1 the new results were compared with those found with the other 
polymers.  
 
 
Figure 5.1. Relation between molecular weight (M [kDa]) and mucoadhesive properties 
(Fmax [mN]). 
 
Data highlight that the mucoadhesive properties of the NaCMC standards match the 
results previously obtained and this means that the molecular weight is a key factor in 
determining the mucoadhesive properties.  
However, the choice of the mucoadhesive polymer must be made taking into account 
also the chemical nature of the polymer.  
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It is hence possible to make a few remarks:  
 generally, natural polymers with complex structure such as xanthan gum and 
tragacanth gum can present lower mucoadhesion due to a reduction of the 
interaction between polymer and mucin; 
 mucoadhesion of nonionic polymers is facilitated by the formation of a 
viscous gel layer; 
 mucoadhesion of tablets is influenced by the nature of the excipient and drug; 
 mucoadhesion of tablets is influenced by the amount of polymer, the higher 
the amount of polymer the higher the mucoadhesion;  
 during the formulation of mucoadhesive tablets it is important also consider 
tha thydrophilic polymers having mucoadhesive properties could reduce the 
release rate of the drug. 
 
The study of the polymer conformation in aqueous medium could represent a future 
goal in order to further investigate the mucoadhesion phenomenon. 
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